[
    {
        "id": 40,
        "type": "assertion",
        "name": "AID40",
        "summary": "FLT3 tyrosine kinase domain mutations at residue I836 in relapsed / refractory acute myeloid leukemia (AML) are sensitive to Gilteritinib, a Type I FLT3 inhibitor.",
        "description": "Mutations in the FMS-like tyrosine kinase 3 (FLT3) gene are the most common mutations in acute myeloid leukemia (AML). 5 to 10% of AML is associated with activating point mutations in the FLT3 tyrosine kinase domain (TKD), including at the residue I836. FLT3 TKD mutations, such as I836 are a commonly reported mechanism of clinical resistance to type II FLT3 inhibitors (sorafenib, quizartinib and ponatinib), which bind only the inactive kinase conformation. However, Gilteritinib (an oral inhibitor of FLT3 and AXL) demonstrated significant single-agent activity in R/R (Relapsed or Refractory) AML with FLT3 ITD, D835, I836 mutations, achieving an overall response rate of 40%. A randomized phase 3 study of Gilteritinib (ADMIRAL trial, NCT02421939) compared with salvage chemotherapy in AML demonstrated a significant overall survival benefit in the gilteritinib arm (9.3 months) compared with chemotherapy (5.6 months). Event-free survival in the gilteritinib arm was also superior (Perl AE, et al., 2019). Based on findings from this study, the US Food and Drug Administration (FDA) approved Gilteritinib as the first FLT3 inhibitor indicated for use as monotherapy R/R AML with FLT3 ITD mutations or TKD D835 or I836 mutations.",
        "gene_id": 24,
        "variant_id": 3232,
        "disease": {
            "id": 3,
            "name": "Acute Myeloid Leukemia",
            "display_name": "Acute Myeloid Leukemia",
            "doid": "9119",
            "disease_url": "http://www.disease-ontology.org/?id=DOID:9119"
        },
        "drugs": [
            {
                "id": 641,
                "name": "Gilteritinib",
                "ncit_id": "C116722",
                "aliases": [
                    "Xospata",
                    "ASP2215",
                    "ASP-2215",
                    "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide"
                ]
            }
        ],
        "evidence_type": "Predictive",
        "evidence_direction": "Supports",
        "clinical_significance": "Sensitivity/Response",
        "evidence_item_count": 2,
        "fda_regulatory_approval": true,
        "status": "submitted",
        "open_change_count": 1,
        "pending_evidence_count": 0,
        "flagged": false,
        "updated_at": "2020-11-18T23:03:32.478Z",
        "nccn_guideline": "Acute Myeloid Leukemia",
        "nccn_guideline_version": "v1.2020",
        "amp_level": "Tier I - Level A",
        "_evidence_items": [
            {
                "id": 7283,
                "name": "EID7283",
                "description": "In a phase 1/2 trial, patients with refractory or relapsed AML with FLT3 mutation (n=191; ITD n=162, D835 n=13, ITD-D835 n=16) received gilteritinib. 49% (93/191) of patients achieved an overall response, 9% (n=18) complete remission, 5% (n=10) complete remission with incomplete platelet recovery, 22% (n=42) complete remission with incomplete hematological recovery, and 12% (n=23) reached partial remission. The refractory or relapsed AML FLT wildtype group treated with gilteritinib(n=58) had lower overall response rate (12%), complete remission (2%), complete remission with incomplete platelet recovery (0%), complete remission with incomplete hematological recovery (7%), and fewer reached partiral remission (3%). Also, bone marrow myeloblast reduction was greater in FLT3 mutant patients compared to FLT3 wildtype.",
                "disease": {
                    "id": 3,
                    "name": "Acute Myeloid Leukemia",
                    "display_name": "Acute Myeloid Leukemia",
                    "doid": "9119",
                    "disease_url": "http://www.disease-ontology.org/?id=DOID:9119"
                },
                "drugs": [
                    {
                        "id": 641,
                        "name": "Gilteritinib",
                        "ncit_id": "C116722",
                        "aliases": [
                            "Xospata",
                            "ASP2215",
                            "ASP-2215",
                            "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide"
                        ]
                    }
                ],
                "rating": 4,
                "evidence_level": "B",
                "evidence_type": "Predictive",
                "clinical_significance": "Sensitivity/Response",
                "evidence_direction": "Supports",
                "variant_origin": "Somatic",
                "drug_interaction_type": null,
                "status": "accepted",
                "open_change_count": 0,
                "type": "evidence",
                "source": {
                    "id": 2871,
                    "name": "Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.",
                    "citation": "Perl et al., 2017, Lancet Oncol.",
                    "citation_id": "28645776",
                    "source_type": "PubMed",
                    "asco_abstract_id": null,
                    "source_url": "http://www.ncbi.nlm.nih.gov/pubmed/28645776",
                    "open_access": true,
                    "pmc_id": "PMC5572576",
                    "publication_date": {
                        "year": 2017
                    },
                    "journal": "Lancet Oncol.",
                    "full_journal_title": "The Lancet. Oncology",
                    "status": "fully curated",
                    "is_review": false,
                    "clinical_trials": [
                        {
                            "nct_id": "NCT02014558",
                            "name": "Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
                            "description": "The objective of this study was to assess the safety and tolerability, including the maximum tolerated dose, of gilteritinib in participants with relapsed or treatment-refractory acute myeloid leukemia (AML). This study also determined the pharmacokinetic (PK) parameters of gilteritinib.",
                            "clinical_trial_url": "https://clinicaltrials.gov/show/NCT02014558"
                        }
                    ]
                },
                "flagged": false,
                "variant_id": 519,
                "phenotypes": [],
                "updated_at": "2020-07-15T01:30:21.618Z",
                "_assertions": [
                    {
                        "id": 33,
                        "type": "assertion",
                        "name": "AID33",
                        "summary": "FLT3 tyrosine kinase domain mutations at residue D835 in relapsed / refractory acute myeloid leukemia (AML) are sensitive to Gilteritinib, a Type I FLT3 inhibitor.",
                        "description": "Mutations in the FMS-like tyrosine kinase 3 (FLT3) gene are the most common mutations in acute myeloid leukemia (AML). 5 to 10% of AML is associated with activating point mutations in the FLT3 tyrosine kinase domain (TKD), particularly at the residue D835. FLT3 TKD mutations at the D835 residue are a commonly reported mechanism of clinical resistance to type II FLT3 inhibitors (sorafenib, quizartinib and ponatinib), which bind only the inactive kinase conformation. However, Gilteritinib, an oral inhibitor of FLT3 and AXL demonstrated preclinical activity against type II FLT3 inhibitor resistance-conferring D835 mutations and clinical activity as monotherapy in Relapsed/Refractory (R/R) FLT3-mutated AML. In the phase 1/2 CHRYSALIS clinical trial (Perl AE, et al., 2017), Gilteritinib demonstrated significant single-agent activity in R/R AML with FLT3 ITD, D835, I836 mutations, achieving an overall response rate of 40%. A randomized phase 3 study of Gilteritinib (ADMIRAL trial, NCT02421939) compared with salvage chemotherapy in AML demonstrated a significant overall survival benefit in the gilteritinib arm (9.3 months) compared with chemotherapy (5.6 months). Event-free survival in the gilteritinib arm was also superior (Perl AE, et al., 2019). Based on findings from this study, the US Food and Drug Administration (FDA) approved Gilteritinib as the first FLT3 inhibitor indicated for use as monotherapy R/R AML with FLT3 ITD mutations or TKD D835 or I836 mutations.",
                        "gene_id": 24,
                        "variant_id": 437,
                        "disease": {
                            "id": 3,
                            "name": "Acute Myeloid Leukemia",
                            "display_name": "Acute Myeloid Leukemia",
                            "doid": "9119",
                            "disease_url": "http://www.disease-ontology.org/?id=DOID:9119"
                        },
                        "drugs": [
                            {
                                "id": 641,
                                "name": "Gilteritinib",
                                "ncit_id": "C116722",
                                "aliases": [
                                    "Xospata",
                                    "ASP2215",
                                    "ASP-2215",
                                    "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide"
                                ]
                            }
                        ],
                        "evidence_type": "Predictive",
                        "evidence_direction": "Supports",
                        "clinical_significance": "Sensitivity/Response",
                        "evidence_item_count": 5,
                        "fda_regulatory_approval": true,
                        "status": "submitted",
                        "open_change_count": 1,
                        "pending_evidence_count": 0,
                        "flagged": false,
                        "updated_at": "2020-11-17T23:41:35.796Z"
                    },
                    {
                        "id": 40,
                        "type": "assertion",
                        "name": "AID40",
                        "summary": "FLT3 tyrosine kinase domain mutations at residue I836 in relapsed / refractory acute myeloid leukemia (AML) are sensitive to Gilteritinib, a Type I FLT3 inhibitor.",
                        "description": "Mutations in the FMS-like tyrosine kinase 3 (FLT3) gene are the most common mutations in acute myeloid leukemia (AML). 5 to 10% of AML is associated with activating point mutations in the FLT3 tyrosine kinase domain (TKD), including at the residue I836. FLT3 TKD mutations, such as I836 are a commonly reported mechanism of clinical resistance to type II FLT3 inhibitors (sorafenib, quizartinib and ponatinib), which bind only the inactive kinase conformation. However, Gilteritinib (an oral inhibitor of FLT3 and AXL) demonstrated significant single-agent activity in R/R (Relapsed or Refractory) AML with FLT3 ITD, D835, I836 mutations, achieving an overall response rate of 40%. A randomized phase 3 study of Gilteritinib (ADMIRAL trial, NCT02421939) compared with salvage chemotherapy in AML demonstrated a significant overall survival benefit in the gilteritinib arm (9.3 months) compared with chemotherapy (5.6 months). Event-free survival in the gilteritinib arm was also superior (Perl AE, et al., 2019). Based on findings from this study, the US Food and Drug Administration (FDA) approved Gilteritinib as the first FLT3 inhibitor indicated for use as monotherapy R/R AML with FLT3 ITD mutations or TKD D835 or I836 mutations.",
                        "gene_id": 24,
                        "variant_id": 3232,
                        "disease": {
                            "id": 3,
                            "name": "Acute Myeloid Leukemia",
                            "display_name": "Acute Myeloid Leukemia",
                            "doid": "9119",
                            "disease_url": "http://www.disease-ontology.org/?id=DOID:9119"
                        },
                        "drugs": [
                            {
                                "id": 641,
                                "name": "Gilteritinib",
                                "ncit_id": "C116722",
                                "aliases": [
                                    "Xospata",
                                    "ASP2215",
                                    "ASP-2215",
                                    "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide"
                                ]
                            }
                        ],
                        "evidence_type": "Predictive",
                        "evidence_direction": "Supports",
                        "clinical_significance": "Sensitivity/Response",
                        "evidence_item_count": 2,
                        "fda_regulatory_approval": true,
                        "status": "submitted",
                        "open_change_count": 1,
                        "pending_evidence_count": 0,
                        "flagged": false,
                        "updated_at": "2020-11-18T23:03:32.478Z"
                    },
                    {
                        "id": 38,
                        "type": "assertion",
                        "name": "AID38",
                        "summary": "FLT3 internal tandem duplication (ITD) mutations in relapsed / refractory acute myeloid leukemia (AML) are sensitive to Gilteritinib, a Type I FLT3 inhibitor.",
                        "description": "The constitutively activating FLT3 internal tandem duplication (ITD) mutation appears in approximately 20-30% of AML patients and are associated with high risk, high relapse rates and poor clinical outcome. The type I selective second-generation oral inhibitor, gilteritinib, received initial global approval for use to treat adults with relapsed or refractory (R/R) FLT3 ITD positive AML in Japan in September 2018. Based on interim results of the ADMIRAL trail (Perl AE, et al., 2019), the FDA approved the drug for treatment of adult R/R AML with FLT3 ITD mutations in November 2018. The FDA approved companion diagnostic, LeukoStrat CDx FLT3 Mutation assay. NCCN AML guidelines classify gilteritinib as a category 1 recommendation for R/R AML patients harboring FLT3 ITD.",
                        "gene_id": 24,
                        "variant_id": 55,
                        "disease": {
                            "id": 3,
                            "name": "Acute Myeloid Leukemia",
                            "display_name": "Acute Myeloid Leukemia",
                            "doid": "9119",
                            "disease_url": "http://www.disease-ontology.org/?id=DOID:9119"
                        },
                        "drugs": [
                            {
                                "id": 641,
                                "name": "Gilteritinib",
                                "ncit_id": "C116722",
                                "aliases": [
                                    "Xospata",
                                    "ASP2215",
                                    "ASP-2215",
                                    "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide"
                                ]
                            }
                        ],
                        "evidence_type": "Predictive",
                        "evidence_direction": "Supports",
                        "clinical_significance": "Sensitivity/Response",
                        "evidence_item_count": 4,
                        "fda_regulatory_approval": true,
                        "status": "accepted",
                        "open_change_count": 0,
                        "pending_evidence_count": 0,
                        "flagged": false,
                        "updated_at": "2020-12-03T04:02:19.779Z"
                    }
                ],
                "errors": {},
                "lifecycle_actions": {
                    "submitted": {
                        "timestamp": "2019-05-02T21:48:22.075Z",
                        "user": {
                            "id": 394,
                            "name": "Hideaki Takahashi",
                            "last_seen_at": "2021-01-12T15:36:26.782Z",
                            "username": "HideakiTakahashi",
                            "role": "curator",
                            "avatar_url": "https://secure.gravatar.com/avatar/ec8707f7f3abe22766f19ac45d6ba5a8.png?d=identicon\u0026r=pg\u0026s=32",
                            "avatars": {
                                "x128": "https://secure.gravatar.com/avatar/ec8707f7f3abe22766f19ac45d6ba5a8.png?d=identicon\u0026r=pg\u0026s=128",
                                "x64": "https://secure.gravatar.com/avatar/ec8707f7f3abe22766f19ac45d6ba5a8.png?d=identicon\u0026r=pg\u0026s=64",
                                "x32": "https://secure.gravatar.com/avatar/ec8707f7f3abe22766f19ac45d6ba5a8.png?d=identicon\u0026r=pg\u0026s=32",
                                "x14": "https://secure.gravatar.com/avatar/ec8707f7f3abe22766f19ac45d6ba5a8.png?d=identicon\u0026r=pg\u0026s=14"
                            },
                            "area_of_expertise": "Clinical Scientist",
                            "orcid": "0000-0002-3184-2513",
                            "display_name": "HideakiTakahashi",
                            "created_at": "2017-03-02T06:21:12.703Z",
                            "url": "",
                            "twitter_handle": "takahashihide3",
                            "facebook_profile": "hideaki.takahashi.319",
                            "linkedin_profile": "",
                            "bio": "Dr. Takahashi is a medical oncologist at National Cancer Center Hospital East, Japan. He contributes to nation-wide cancer genome screening and data storage program, SCRUM-JAPAN. He was trained as medical oncologist at National Cancer Center Hospital East, and his speciality is Hepatobiliary and Pancreatic cancer. He received MD from Okayama university medical school.",
                            "country": {
                                "id": 100,
                                "iso": "JP",
                                "name": "Japan"
                            },
                            "featured_expert": false,
                            "accepted_license": null,
                            "signup_complete": null,
                            "organizations": [
                                {
                                    "id": 10,
                                    "name": "National Cancer Center Hospital East",
                                    "url": "https://www.ncc.go.jp/en/ncce/index.html",
                                    "description": "The National Cancer Center Hospital East (NCCHE) is a medical research organization in Kashiwa city, near Tokyo, Japan.\r\n\r\nWe have introduced NGS testing in clinical setting since 2008 and NCCHE is one of the leading institutions for precision cancer medicine in Japan.\r\n\r\nWe are also conducting a nationwide cancer profiling and monitoring project based on cutting edge technology at each time point, and have been facilitating patient enrollment to a biomarker selected clinical trial through-out our country.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/010/x256/ncche-org.png?1592507670",
                                        "x128": "/system/organizations/profile_images/000/000/010/x128/ncche-org.png?1592507670",
                                        "x64": "/system/organizations/profile_images/000/000/010/x64/ncche-org.png?1592507670",
                                        "x32": "/system/organizations/profile_images/000/000/010/x32/ncche-org.png?1592507670",
                                        "x14": "/system/organizations/profile_images/000/000/010/x14/ncche-org.png?1592507670"
                                    },
                                    "parent": {}
                                }
                            ],
                            "most_recent_organization": {
                                "id": 10,
                                "name": "National Cancer Center Hospital East",
                                "url": "https://www.ncc.go.jp/en/ncce/index.html",
                                "description": "The National Cancer Center Hospital East (NCCHE) is a medical research organization in Kashiwa city, near Tokyo, Japan.\r\n\r\nWe have introduced NGS testing in clinical setting since 2008 and NCCHE is one of the leading institutions for precision cancer medicine in Japan.\r\n\r\nWe are also conducting a nationwide cancer profiling and monitoring project based on cutting edge technology at each time point, and have been facilitating patient enrollment to a biomarker selected clinical trial through-out our country.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/010/x256/ncche-org.png?1592507670",
                                    "x128": "/system/organizations/profile_images/000/000/010/x128/ncche-org.png?1592507670",
                                    "x64": "/system/organizations/profile_images/000/000/010/x64/ncche-org.png?1592507670",
                                    "x32": "/system/organizations/profile_images/000/000/010/x32/ncche-org.png?1592507670",
                                    "x14": "/system/organizations/profile_images/000/000/010/x14/ncche-org.png?1592507670"
                                },
                                "parent": {}
                            },
                            "conflict_of_interest": {
                                "coi_valid": "missing",
                                "details": {}
                            }
                        },
                        "organization": {
                            "id": 10,
                            "name": "National Cancer Center Hospital East",
                            "url": "https://www.ncc.go.jp/en/ncce/index.html",
                            "description": "The National Cancer Center Hospital East (NCCHE) is a medical research organization in Kashiwa city, near Tokyo, Japan.\r\n\r\nWe have introduced NGS testing in clinical setting since 2008 and NCCHE is one of the leading institutions for precision cancer medicine in Japan.\r\n\r\nWe are also conducting a nationwide cancer profiling and monitoring project based on cutting edge technology at each time point, and have been facilitating patient enrollment to a biomarker selected clinical trial through-out our country.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/010/x256/ncche-org.png?1592507670",
                                "x128": "/system/organizations/profile_images/000/000/010/x128/ncche-org.png?1592507670",
                                "x64": "/system/organizations/profile_images/000/000/010/x64/ncche-org.png?1592507670",
                                "x32": "/system/organizations/profile_images/000/000/010/x32/ncche-org.png?1592507670",
                                "x14": "/system/organizations/profile_images/000/000/010/x14/ncche-org.png?1592507670"
                            },
                            "parent": {}
                        }
                    },
                    "last_modified": {
                        "timestamp": "2020-07-14T19:32:29.891Z",
                        "user": {
                            "id": 1053,
                            "name": "Jason Saliba",
                            "last_seen_at": "2021-02-02T09:04:58.553Z",
                            "username": "JasonSaliba",
                            "role": "admin",
                            "avatar_url": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=32",
                            "avatars": {
                                "x128": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=128",
                                "x64": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=64",
                                "x32": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=32",
                                "x14": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=14"
                            },
                            "area_of_expertise": "Research Scientist",
                            "orcid": "0000-0003-3035-2296",
                            "display_name": "JasonSaliba",
                            "created_at": "2020-01-07T17:53:13.677Z",
                            "url": "",
                            "twitter_handle": "jasonmsaliba",
                            "facebook_profile": "",
                            "linkedin_profile": "",
                            "bio": "Dr. Saliba is a Senior Scientist in the Griffith Lab at the Washington University School of Medicine. He received his PhD in Molecular and Human Genetics from Baylor College of Medicine. During his training, he studied germline susceptibility genes and somatic relapse drivers in pediatric leukemia with a special interest in pharmacogenetics. His primary focus is the editorial maintenance of CIViC along with driving the evolution of the knowledgebase and fostering enhancements through training and collaborations.",
                            "country": {
                                "id": 214,
                                "iso": "US",
                                "name": "United States"
                            },
                            "featured_expert": false,
                            "accepted_license": null,
                            "signup_complete": null,
                            "organizations": [
                                {
                                    "id": 12,
                                    "name": "Washington University in Saint Louis",
                                    "url": "https://wustl.edu/",
                                    "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                        "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                        "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                        "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                        "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                    },
                                    "parent": {}
                                },
                                {
                                    "id": 9,
                                    "name": "Pediatric Cancer Task Force",
                                    "url": "https://www.clinicalgenome.org/working-groups/somatic/pediatric-task-team/\r\n",
                                    "description": "Pediatric Cancer Task Force within the ClinGen Somatic Work Group focuses on curation of clinically relevant somatic variants in pediatric cancers. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/009/x256/clingen-vcep-1.png?1596737215",
                                        "x128": "/system/organizations/profile_images/000/000/009/x128/clingen-vcep-1.png?1596737215",
                                        "x64": "/system/organizations/profile_images/000/000/009/x64/clingen-vcep-1.png?1596737215",
                                        "x32": "/system/organizations/profile_images/000/000/009/x32/clingen-vcep-1.png?1596737215",
                                        "x14": "/system/organizations/profile_images/000/000/009/x14/clingen-vcep-1.png?1596737215"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 1,
                                    "name": "The McDonnell Genome Institute",
                                    "url": "http://genome.wustl.edu/",
                                    "description": "The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/001/x256/mgi-org.png?1592507909",
                                        "x128": "/system/organizations/profile_images/000/000/001/x128/mgi-org.png?1592507909",
                                        "x64": "/system/organizations/profile_images/000/000/001/x64/mgi-org.png?1592507909",
                                        "x32": "/system/organizations/profile_images/000/000/001/x32/mgi-org.png?1592507909",
                                        "x14": "/system/organizations/profile_images/000/000/001/x14/mgi-org.png?1592507909"
                                    },
                                    "parent": {
                                        "id": 12,
                                        "name": "Washington University in Saint Louis",
                                        "url": "https://wustl.edu/",
                                        "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                            "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                            "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                            "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                            "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 13,
                                    "name": "Genitourinary Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/genitourinary-cancer/",
                                    "description": "The Genitourinary Cancer Taskforce will embark on variant curation for FGFR and AR genes, using Clinical Interpretations of Variants in Cancer (CIViC) platform for variant curation.  The somatic variants should be examined and curated for the clinical significance/clinical management of patients, i.e. their role in the diagnosis, prognosis, therapeutic outcomes, prevention of the disease, or disease surveillance.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/013/x256/clingen-vcep-6.png?1596737087",
                                        "x128": "/system/organizations/profile_images/000/000/013/x128/clingen-vcep-6.png?1596737087",
                                        "x64": "/system/organizations/profile_images/000/000/013/x64/clingen-vcep-6.png?1596737087",
                                        "x32": "/system/organizations/profile_images/000/000/013/x32/clingen-vcep-6.png?1596737087",
                                        "x14": "/system/organizations/profile_images/000/000/013/x14/clingen-vcep-6.png?1596737087"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 11,
                                    "name": "Hematologic Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                                    "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                        "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                        "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                        "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                        "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 14,
                                    "name": "NTRK VCEP",
                                    "url": "",
                                    "description": "The ClinGen NTRK expert panel will develop a sustainable process for systematic consensus review of fusions and associated secondary alterations in NTRK1, NTRK2, and NTRK3 genes that drive oncogenesis and response to targeted therapy. The group will focus on further specifying and piloting the AMP/ASCO/CAP guidelines (PMID: 27993330) for somatic variant classification and the diagnostic and therapeutic significance of NTRK fusions in cancers. After consensus classification, the panel will make these interpretations publicly available through the CIViC knowledgebase.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/014/x256/clingen-vcep-2.png?1596737246",
                                        "x128": "/system/organizations/profile_images/000/000/014/x128/clingen-vcep-2.png?1596737246",
                                        "x64": "/system/organizations/profile_images/000/000/014/x64/clingen-vcep-2.png?1596737246",
                                        "x32": "/system/organizations/profile_images/000/000/014/x32/clingen-vcep-2.png?1596737246",
                                        "x14": "/system/organizations/profile_images/000/000/014/x14/clingen-vcep-2.png?1596737246"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                }
                            ],
                            "most_recent_organization": {
                                "id": 1,
                                "name": "The McDonnell Genome Institute",
                                "url": "http://genome.wustl.edu/",
                                "description": "The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/001/x256/mgi-org.png?1592507909",
                                    "x128": "/system/organizations/profile_images/000/000/001/x128/mgi-org.png?1592507909",
                                    "x64": "/system/organizations/profile_images/000/000/001/x64/mgi-org.png?1592507909",
                                    "x32": "/system/organizations/profile_images/000/000/001/x32/mgi-org.png?1592507909",
                                    "x14": "/system/organizations/profile_images/000/000/001/x14/mgi-org.png?1592507909"
                                },
                                "parent": {
                                    "id": 12,
                                    "name": "Washington University in Saint Louis",
                                    "url": "https://wustl.edu/",
                                    "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                        "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                        "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                        "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                        "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                    },
                                    "parent": {}
                                }
                            },
                            "conflict_of_interest": {
                                "coi_valid": "valid",
                                "details": {
                                    "coi_present": false,
                                    "coi_statement": "",
                                    "created_at": "2020-05-08T15:59:47.263Z",
                                    "expires_at": "2021-05-08T15:59:47.263Z"
                                }
                            }
                        },
                        "organization": {
                            "id": 1,
                            "name": "The McDonnell Genome Institute",
                            "url": "http://genome.wustl.edu/",
                            "description": "The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/001/x256/mgi-org.png?1592507909",
                                "x128": "/system/organizations/profile_images/000/000/001/x128/mgi-org.png?1592507909",
                                "x64": "/system/organizations/profile_images/000/000/001/x64/mgi-org.png?1592507909",
                                "x32": "/system/organizations/profile_images/000/000/001/x32/mgi-org.png?1592507909",
                                "x14": "/system/organizations/profile_images/000/000/001/x14/mgi-org.png?1592507909"
                            },
                            "parent": {
                                "id": 12,
                                "name": "Washington University in Saint Louis",
                                "url": "https://wustl.edu/",
                                "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                    "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                    "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                    "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                    "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                },
                                "parent": {}
                            }
                        }
                    },
                    "last_reviewed": {
                        "timestamp": "2020-07-15T01:30:21.628Z",
                        "user": {
                            "id": 341,
                            "name": "Shruti Rao",
                            "last_seen_at": "2021-01-29T17:35:11.856Z",
                            "username": "ShrutiRao",
                            "role": "editor",
                            "avatar_url": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=32",
                            "avatars": {
                                "x128": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=128",
                                "x64": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=64",
                                "x32": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=32",
                                "x14": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=14"
                            },
                            "area_of_expertise": "Research Scientist",
                            "orcid": "0000-0002-7235-0777",
                            "display_name": "ShrutiRao",
                            "created_at": "2017-02-02T15:43:46.594Z",
                            "url": "",
                            "twitter_handle": "",
                            "facebook_profile": "",
                            "linkedin_profile": "https://www.linkedin.com/in/shrutiarao/",
                            "bio": "",
                            "country": {
                                "id": 214,
                                "iso": "US",
                                "name": "United States"
                            },
                            "featured_expert": false,
                            "accepted_license": null,
                            "signup_complete": null,
                            "organizations": [
                                {
                                    "id": 9,
                                    "name": "Pediatric Cancer Task Force",
                                    "url": "https://www.clinicalgenome.org/working-groups/somatic/pediatric-task-team/\r\n",
                                    "description": "Pediatric Cancer Task Force within the ClinGen Somatic Work Group focuses on curation of clinically relevant somatic variants in pediatric cancers. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/009/x256/clingen-vcep-1.png?1596737215",
                                        "x128": "/system/organizations/profile_images/000/000/009/x128/clingen-vcep-1.png?1596737215",
                                        "x64": "/system/organizations/profile_images/000/000/009/x64/clingen-vcep-1.png?1596737215",
                                        "x32": "/system/organizations/profile_images/000/000/009/x32/clingen-vcep-1.png?1596737215",
                                        "x14": "/system/organizations/profile_images/000/000/009/x14/clingen-vcep-1.png?1596737215"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 2,
                                    "name": "ClinGen",
                                    "url": "https://www.clinicalgenome.org/",
                                    "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                        "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                        "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                        "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                        "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                    },
                                    "parent": {}
                                },
                                {
                                    "id": 13,
                                    "name": "Genitourinary Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/genitourinary-cancer/",
                                    "description": "The Genitourinary Cancer Taskforce will embark on variant curation for FGFR and AR genes, using Clinical Interpretations of Variants in Cancer (CIViC) platform for variant curation.  The somatic variants should be examined and curated for the clinical significance/clinical management of patients, i.e. their role in the diagnosis, prognosis, therapeutic outcomes, prevention of the disease, or disease surveillance.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/013/x256/clingen-vcep-6.png?1596737087",
                                        "x128": "/system/organizations/profile_images/000/000/013/x128/clingen-vcep-6.png?1596737087",
                                        "x64": "/system/organizations/profile_images/000/000/013/x64/clingen-vcep-6.png?1596737087",
                                        "x32": "/system/organizations/profile_images/000/000/013/x32/clingen-vcep-6.png?1596737087",
                                        "x14": "/system/organizations/profile_images/000/000/013/x14/clingen-vcep-6.png?1596737087"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 11,
                                    "name": "Hematologic Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                                    "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                        "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                        "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                        "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                        "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 14,
                                    "name": "NTRK VCEP",
                                    "url": "",
                                    "description": "The ClinGen NTRK expert panel will develop a sustainable process for systematic consensus review of fusions and associated secondary alterations in NTRK1, NTRK2, and NTRK3 genes that drive oncogenesis and response to targeted therapy. The group will focus on further specifying and piloting the AMP/ASCO/CAP guidelines (PMID: 27993330) for somatic variant classification and the diagnostic and therapeutic significance of NTRK fusions in cancers. After consensus classification, the panel will make these interpretations publicly available through the CIViC knowledgebase.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/014/x256/clingen-vcep-2.png?1596737246",
                                        "x128": "/system/organizations/profile_images/000/000/014/x128/clingen-vcep-2.png?1596737246",
                                        "x64": "/system/organizations/profile_images/000/000/014/x64/clingen-vcep-2.png?1596737246",
                                        "x32": "/system/organizations/profile_images/000/000/014/x32/clingen-vcep-2.png?1596737246",
                                        "x14": "/system/organizations/profile_images/000/000/014/x14/clingen-vcep-2.png?1596737246"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                }
                            ],
                            "most_recent_organization": {
                                "id": 11,
                                "name": "Hematologic Cancer Taskforce",
                                "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                                "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                    "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                    "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                    "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                    "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                                },
                                "parent": {
                                    "id": 2,
                                    "name": "ClinGen",
                                    "url": "https://www.clinicalgenome.org/",
                                    "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                        "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                        "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                        "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                        "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                    },
                                    "parent": {}
                                }
                            },
                            "conflict_of_interest": {
                                "coi_valid": "valid",
                                "details": {
                                    "coi_present": false,
                                    "coi_statement": "",
                                    "created_at": "2020-12-04T16:49:52.232Z",
                                    "expires_at": "2021-12-04T16:49:52.232Z"
                                }
                            }
                        },
                        "organization": {
                            "id": 2,
                            "name": "ClinGen",
                            "url": "https://www.clinicalgenome.org/",
                            "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                            },
                            "parent": {}
                        }
                    },
                    "last_commented_on": {
                        "timestamp": "2019-11-19T23:41:22.947Z",
                        "user": {
                            "id": 968,
                            "name": "Cam Grisdale",
                            "last_seen_at": "2021-02-01T23:36:08.589Z",
                            "username": "CamGrisdale",
                            "role": "editor",
                            "avatar_url": "https://secure.gravatar.com/avatar/9f5de2e3d507c76e6097725ae9b0e8bd.png?d=identicon\u0026r=pg\u0026s=32",
                            "avatars": {
                                "x128": "https://secure.gravatar.com/avatar/9f5de2e3d507c76e6097725ae9b0e8bd.png?d=identicon\u0026r=pg\u0026s=128",
                                "x64": "https://secure.gravatar.com/avatar/9f5de2e3d507c76e6097725ae9b0e8bd.png?d=identicon\u0026r=pg\u0026s=64",
                                "x32": "https://secure.gravatar.com/avatar/9f5de2e3d507c76e6097725ae9b0e8bd.png?d=identicon\u0026r=pg\u0026s=32",
                                "x14": "https://secure.gravatar.com/avatar/9f5de2e3d507c76e6097725ae9b0e8bd.png?d=identicon\u0026r=pg\u0026s=14"
                            },
                            "area_of_expertise": "Research Scientist",
                            "orcid": "0000-0003-1923-6972",
                            "display_name": "CamGrisdale",
                            "created_at": "2019-06-28T16:49:18.982Z",
                            "url": "",
                            "twitter_handle": "",
                            "facebook_profile": "",
                            "linkedin_profile": "Cameron Grisdale",
                            "bio": "",
                            "country": {
                                "id": 35,
                                "iso": "CA",
                                "name": "Canada"
                            },
                            "featured_expert": false,
                            "accepted_license": null,
                            "signup_complete": null,
                            "organizations": [
                                {
                                    "id": 3,
                                    "name": "BCCA (POGS)",
                                    "url": "http://www.bcgsc.ca/project/pog",
                                    "description": "The BC Cancer Agency’s Personalized OncoGenomics (POG) program is a clinical research initiative that is embedding genomic sequencing into real-time treatment planning for BC patients with incurable cancers.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/003/x256/bcca-pog-org.png?1592507866",
                                        "x128": "/system/organizations/profile_images/000/000/003/x128/bcca-pog-org.png?1592507866",
                                        "x64": "/system/organizations/profile_images/000/000/003/x64/bcca-pog-org.png?1592507866",
                                        "x32": "/system/organizations/profile_images/000/000/003/x32/bcca-pog-org.png?1592507866",
                                        "x14": "/system/organizations/profile_images/000/000/003/x14/bcca-pog-org.png?1592507866"
                                    },
                                    "parent": {}
                                }
                            ],
                            "most_recent_organization": {
                                "id": 3,
                                "name": "BCCA (POGS)",
                                "url": "http://www.bcgsc.ca/project/pog",
                                "description": "The BC Cancer Agency’s Personalized OncoGenomics (POG) program is a clinical research initiative that is embedding genomic sequencing into real-time treatment planning for BC patients with incurable cancers.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/003/x256/bcca-pog-org.png?1592507866",
                                    "x128": "/system/organizations/profile_images/000/000/003/x128/bcca-pog-org.png?1592507866",
                                    "x64": "/system/organizations/profile_images/000/000/003/x64/bcca-pog-org.png?1592507866",
                                    "x32": "/system/organizations/profile_images/000/000/003/x32/bcca-pog-org.png?1592507866",
                                    "x14": "/system/organizations/profile_images/000/000/003/x14/bcca-pog-org.png?1592507866"
                                },
                                "parent": {}
                            },
                            "conflict_of_interest": {
                                "coi_valid": "valid",
                                "details": {
                                    "coi_present": false,
                                    "coi_statement": "",
                                    "created_at": "2020-11-06T00:45:18.372Z",
                                    "expires_at": "2021-11-06T00:45:18.372Z"
                                }
                            }
                        },
                        "organization": {
                            "id": 3,
                            "name": "BCCA (POGS)",
                            "url": "http://www.bcgsc.ca/project/pog",
                            "description": "The BC Cancer Agency’s Personalized OncoGenomics (POG) program is a clinical research initiative that is embedding genomic sequencing into real-time treatment planning for BC patients with incurable cancers.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/003/x256/bcca-pog-org.png?1592507866",
                                "x128": "/system/organizations/profile_images/000/000/003/x128/bcca-pog-org.png?1592507866",
                                "x64": "/system/organizations/profile_images/000/000/003/x64/bcca-pog-org.png?1592507866",
                                "x32": "/system/organizations/profile_images/000/000/003/x32/bcca-pog-org.png?1592507866",
                                "x14": "/system/organizations/profile_images/000/000/003/x14/bcca-pog-org.png?1592507866"
                            },
                            "parent": {}
                        }
                    },
                    "accepted": {
                        "timestamp": "2019-11-07T09:48:29.140Z",
                        "user": {
                            "id": 100,
                            "name": "Damian Rieke",
                            "last_seen_at": "2021-01-14T14:43:10.872Z",
                            "username": "DamianRieke",
                            "role": "editor",
                            "avatar_url": "https://secure.gravatar.com/avatar/baaffa3938cc82f434ca5561e34d3de9.png?d=identicon\u0026r=pg\u0026s=32",
                            "avatars": {
                                "x128": "https://secure.gravatar.com/avatar/baaffa3938cc82f434ca5561e34d3de9.png?d=identicon\u0026r=pg\u0026s=128",
                                "x64": "https://secure.gravatar.com/avatar/baaffa3938cc82f434ca5561e34d3de9.png?d=identicon\u0026r=pg\u0026s=64",
                                "x32": "https://secure.gravatar.com/avatar/baaffa3938cc82f434ca5561e34d3de9.png?d=identicon\u0026r=pg\u0026s=32",
                                "x14": "https://secure.gravatar.com/avatar/baaffa3938cc82f434ca5561e34d3de9.png?d=identicon\u0026r=pg\u0026s=14"
                            },
                            "area_of_expertise": "Clinical Scientist",
                            "orcid": "0000-0003-0027-7977",
                            "display_name": "DamianRieke",
                            "created_at": "2015-12-14T08:37:49.264Z",
                            "url": "https://cccc.charite.de",
                            "twitter_handle": "",
                            "facebook_profile": "",
                            "linkedin_profile": "",
                            "bio": "Damian Rieke is a physician and researcher at the Charité Comprehensive Cancer Center and the Department for Hematology, Oncology and Tumor Immunology at Charité - University Medicine Berlin in Berlin, Germany. His main areas of interest include the development of targeted therapy strategies and the targeted use of immune therapeutics as well as their application in clinic.",
                            "country": {
                                "id": 74,
                                "iso": "DE",
                                "name": "Germany"
                            },
                            "featured_expert": true,
                            "accepted_license": null,
                            "signup_complete": null,
                            "organizations": [
                                {
                                    "id": 5,
                                    "name": "The Charité Comprehensive Cancer Center",
                                    "url": "https://cccc.charite.de/en/",
                                    "description": "Charité – Universitätsmedizin Berlin in Berlin, Germany is one of the largest university hospitals in Europe. The Charité Comprehensive Cancer Center is dedicated to integrating medical, psychological and social care as well as preclinical and clinical research to improve therapies for tumor patients. In collaboration with CIViC, the Charité Comprehensive Cancer Center translates genomic data into therapy, aiming to improve personalized oncology and advance its application in clinical routine.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/005/x256/charite-org.png?1592507820",
                                        "x128": "/system/organizations/profile_images/000/000/005/x128/charite-org.png?1592507820",
                                        "x64": "/system/organizations/profile_images/000/000/005/x64/charite-org.png?1592507820",
                                        "x32": "/system/organizations/profile_images/000/000/005/x32/charite-org.png?1592507820",
                                        "x14": "/system/organizations/profile_images/000/000/005/x14/charite-org.png?1592507820"
                                    },
                                    "parent": {}
                                }
                            ],
                            "most_recent_organization": {
                                "id": 5,
                                "name": "The Charité Comprehensive Cancer Center",
                                "url": "https://cccc.charite.de/en/",
                                "description": "Charité – Universitätsmedizin Berlin in Berlin, Germany is one of the largest university hospitals in Europe. The Charité Comprehensive Cancer Center is dedicated to integrating medical, psychological and social care as well as preclinical and clinical research to improve therapies for tumor patients. In collaboration with CIViC, the Charité Comprehensive Cancer Center translates genomic data into therapy, aiming to improve personalized oncology and advance its application in clinical routine.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/005/x256/charite-org.png?1592507820",
                                    "x128": "/system/organizations/profile_images/000/000/005/x128/charite-org.png?1592507820",
                                    "x64": "/system/organizations/profile_images/000/000/005/x64/charite-org.png?1592507820",
                                    "x32": "/system/organizations/profile_images/000/000/005/x32/charite-org.png?1592507820",
                                    "x14": "/system/organizations/profile_images/000/000/005/x14/charite-org.png?1592507820"
                                },
                                "parent": {}
                            },
                            "conflict_of_interest": {
                                "coi_valid": "conflict",
                                "details": {
                                    "coi_present": true,
                                    "coi_statement": "Consulting: Alacris Theranostics\nHonoraria: Bristol-Myers Squibb, Bayer",
                                    "created_at": "2020-11-18T09:39:45.421Z",
                                    "expires_at": "2021-11-18T09:39:45.421Z"
                                }
                            }
                        },
                        "organization": {
                            "id": 5,
                            "name": "The Charité Comprehensive Cancer Center",
                            "url": "https://cccc.charite.de/en/",
                            "description": "Charité – Universitätsmedizin Berlin in Berlin, Germany is one of the largest university hospitals in Europe. The Charité Comprehensive Cancer Center is dedicated to integrating medical, psychological and social care as well as preclinical and clinical research to improve therapies for tumor patients. In collaboration with CIViC, the Charité Comprehensive Cancer Center translates genomic data into therapy, aiming to improve personalized oncology and advance its application in clinical routine.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/005/x256/charite-org.png?1592507820",
                                "x128": "/system/organizations/profile_images/000/000/005/x128/charite-org.png?1592507820",
                                "x64": "/system/organizations/profile_images/000/000/005/x64/charite-org.png?1592507820",
                                "x32": "/system/organizations/profile_images/000/000/005/x32/charite-org.png?1592507820",
                                "x14": "/system/organizations/profile_images/000/000/005/x14/charite-org.png?1592507820"
                            },
                            "parent": {}
                        }
                    }
                },
                "fields_with_pending_changes": {},
                "gene_id": 24,
                "state_params": {
                    "evidence_item": {
                        "id": 7283,
                        "name": "EID7283"
                    },
                    "variant": {
                        "id": 519,
                        "name": "MUTATION"
                    },
                    "gene": {
                        "id": 24,
                        "name": "FLT3"
                    }
                }
            },
            {
                "id": 7728,
                "name": "EID7728",
                "description": "In this phase 3 trial (ADMIRAL), 371 patients with relapsed or refractory FLT3-mutated AML (required to have FLT3 ITD or TKD D835 or I836 mutations) were randomly assigned in a 2:1 ratio to receive either gilteritinib (n=247, at a dose of 120 mg per day) or salvage chemotherapy (n=124). Median overall survival in the gilteritinib group was significantly longer than in the chemotherapy group (9.3 months vs. 5.6 months; hazard ratio for death, 0.64; 95% confidence interval [CI], 0.49 to 0.83; P\u003c0.001). Median event-free survival was 2.8 months in the gilteritinib group and 0.7 months in the chemotherapy group (hazard ratio for treatment failure or death, 0.79; 95% CI, 0.58 to 1.09). The complete remission rate with full or partial hematologic recovery was 34.0% in the gilteritinib group and 15.3% in the chemotherapy group (risk difference, 18.6 percentage points; 95% CI, 9.8 to 27.4); the percentages with complete remission were 21.1% and 10.5%, respectively (risk difference, 10.6 percentage points; 95% CI, 2.8 to 18.4). Notably, gilteritinib treatment resulted in similar median overall survival (9.3 months vs. 8.0 months) and percentage of complete remission (20.5% vs. 19.0%) in patients with ITD mutations and patients with TKD mutations. The authors concluded gilteritinib therapy in relapsed or refractory FLT3-mutated AML patients resulted longer survival and improved response versus salvage chemotherapy.",
                "disease": {
                    "id": 3,
                    "name": "Acute Myeloid Leukemia",
                    "display_name": "Acute Myeloid Leukemia",
                    "doid": "9119",
                    "disease_url": "http://www.disease-ontology.org/?id=DOID:9119"
                },
                "drugs": [
                    {
                        "id": 641,
                        "name": "Gilteritinib",
                        "ncit_id": "C116722",
                        "aliases": [
                            "Xospata",
                            "ASP2215",
                            "ASP-2215",
                            "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide"
                        ]
                    }
                ],
                "rating": 5,
                "evidence_level": "B",
                "evidence_type": "Predictive",
                "clinical_significance": "Sensitivity/Response",
                "evidence_direction": "Supports",
                "variant_origin": "Somatic",
                "drug_interaction_type": null,
                "status": "accepted",
                "open_change_count": 0,
                "type": "evidence",
                "source": {
                    "id": 3080,
                    "name": "Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.",
                    "citation": "Perl et al., 2019, N. Engl. J. Med.",
                    "citation_id": "31665578",
                    "source_type": "PubMed",
                    "asco_abstract_id": null,
                    "source_url": "http://www.ncbi.nlm.nih.gov/pubmed/31665578",
                    "open_access": null,
                    "pmc_id": null,
                    "publication_date": {
                        "year": 2019,
                        "day": 31
                    },
                    "journal": "N. Engl. J. Med.",
                    "full_journal_title": "The New England journal of medicine",
                    "status": "fully curated",
                    "is_review": false,
                    "clinical_trials": [
                        {
                            "nct_id": "NCT02421939",
                            "name": "A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation",
                            "description": "The purpose of this study is to determine the clinical benefit of ASP2215 therapy in participants with FMS-like tyrosine kinase (FLT3) mutated acute myeloid leukemia (AML) who are refractory to or have relapsed after first-line AML therapy as shown with overall survival (OS) compared to salvage chemotherapy, and to determine the efficacy of ASP2215 therapy as assessed by the rate of complete remission and complete remission with partial hematological recovery (CR/CRh) in these participants. This study will also determine the overall efficacy in event-free survival (EFS) and complete remission (CR) rate of ASP2215 compared to salvage chemotherapy.",
                            "clinical_trial_url": "https://clinicaltrials.gov/show/NCT02421939"
                        }
                    ]
                },
                "flagged": false,
                "variant_id": 519,
                "phenotypes": [],
                "updated_at": "2020-07-14T01:21:25.791Z",
                "_assertions": [
                    {
                        "id": 33,
                        "type": "assertion",
                        "name": "AID33",
                        "summary": "FLT3 tyrosine kinase domain mutations at residue D835 in relapsed / refractory acute myeloid leukemia (AML) are sensitive to Gilteritinib, a Type I FLT3 inhibitor.",
                        "description": "Mutations in the FMS-like tyrosine kinase 3 (FLT3) gene are the most common mutations in acute myeloid leukemia (AML). 5 to 10% of AML is associated with activating point mutations in the FLT3 tyrosine kinase domain (TKD), particularly at the residue D835. FLT3 TKD mutations at the D835 residue are a commonly reported mechanism of clinical resistance to type II FLT3 inhibitors (sorafenib, quizartinib and ponatinib), which bind only the inactive kinase conformation. However, Gilteritinib, an oral inhibitor of FLT3 and AXL demonstrated preclinical activity against type II FLT3 inhibitor resistance-conferring D835 mutations and clinical activity as monotherapy in Relapsed/Refractory (R/R) FLT3-mutated AML. In the phase 1/2 CHRYSALIS clinical trial (Perl AE, et al., 2017), Gilteritinib demonstrated significant single-agent activity in R/R AML with FLT3 ITD, D835, I836 mutations, achieving an overall response rate of 40%. A randomized phase 3 study of Gilteritinib (ADMIRAL trial, NCT02421939) compared with salvage chemotherapy in AML demonstrated a significant overall survival benefit in the gilteritinib arm (9.3 months) compared with chemotherapy (5.6 months). Event-free survival in the gilteritinib arm was also superior (Perl AE, et al., 2019). Based on findings from this study, the US Food and Drug Administration (FDA) approved Gilteritinib as the first FLT3 inhibitor indicated for use as monotherapy R/R AML with FLT3 ITD mutations or TKD D835 or I836 mutations.",
                        "gene_id": 24,
                        "variant_id": 437,
                        "disease": {
                            "id": 3,
                            "name": "Acute Myeloid Leukemia",
                            "display_name": "Acute Myeloid Leukemia",
                            "doid": "9119",
                            "disease_url": "http://www.disease-ontology.org/?id=DOID:9119"
                        },
                        "drugs": [
                            {
                                "id": 641,
                                "name": "Gilteritinib",
                                "ncit_id": "C116722",
                                "aliases": [
                                    "Xospata",
                                    "ASP2215",
                                    "ASP-2215",
                                    "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide"
                                ]
                            }
                        ],
                        "evidence_type": "Predictive",
                        "evidence_direction": "Supports",
                        "clinical_significance": "Sensitivity/Response",
                        "evidence_item_count": 5,
                        "fda_regulatory_approval": true,
                        "status": "submitted",
                        "open_change_count": 1,
                        "pending_evidence_count": 0,
                        "flagged": false,
                        "updated_at": "2020-11-17T23:41:35.796Z"
                    },
                    {
                        "id": 40,
                        "type": "assertion",
                        "name": "AID40",
                        "summary": "FLT3 tyrosine kinase domain mutations at residue I836 in relapsed / refractory acute myeloid leukemia (AML) are sensitive to Gilteritinib, a Type I FLT3 inhibitor.",
                        "description": "Mutations in the FMS-like tyrosine kinase 3 (FLT3) gene are the most common mutations in acute myeloid leukemia (AML). 5 to 10% of AML is associated with activating point mutations in the FLT3 tyrosine kinase domain (TKD), including at the residue I836. FLT3 TKD mutations, such as I836 are a commonly reported mechanism of clinical resistance to type II FLT3 inhibitors (sorafenib, quizartinib and ponatinib), which bind only the inactive kinase conformation. However, Gilteritinib (an oral inhibitor of FLT3 and AXL) demonstrated significant single-agent activity in R/R (Relapsed or Refractory) AML with FLT3 ITD, D835, I836 mutations, achieving an overall response rate of 40%. A randomized phase 3 study of Gilteritinib (ADMIRAL trial, NCT02421939) compared with salvage chemotherapy in AML demonstrated a significant overall survival benefit in the gilteritinib arm (9.3 months) compared with chemotherapy (5.6 months). Event-free survival in the gilteritinib arm was also superior (Perl AE, et al., 2019). Based on findings from this study, the US Food and Drug Administration (FDA) approved Gilteritinib as the first FLT3 inhibitor indicated for use as monotherapy R/R AML with FLT3 ITD mutations or TKD D835 or I836 mutations.",
                        "gene_id": 24,
                        "variant_id": 3232,
                        "disease": {
                            "id": 3,
                            "name": "Acute Myeloid Leukemia",
                            "display_name": "Acute Myeloid Leukemia",
                            "doid": "9119",
                            "disease_url": "http://www.disease-ontology.org/?id=DOID:9119"
                        },
                        "drugs": [
                            {
                                "id": 641,
                                "name": "Gilteritinib",
                                "ncit_id": "C116722",
                                "aliases": [
                                    "Xospata",
                                    "ASP2215",
                                    "ASP-2215",
                                    "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide"
                                ]
                            }
                        ],
                        "evidence_type": "Predictive",
                        "evidence_direction": "Supports",
                        "clinical_significance": "Sensitivity/Response",
                        "evidence_item_count": 2,
                        "fda_regulatory_approval": true,
                        "status": "submitted",
                        "open_change_count": 1,
                        "pending_evidence_count": 0,
                        "flagged": false,
                        "updated_at": "2020-11-18T23:03:32.478Z"
                    },
                    {
                        "id": 38,
                        "type": "assertion",
                        "name": "AID38",
                        "summary": "FLT3 internal tandem duplication (ITD) mutations in relapsed / refractory acute myeloid leukemia (AML) are sensitive to Gilteritinib, a Type I FLT3 inhibitor.",
                        "description": "The constitutively activating FLT3 internal tandem duplication (ITD) mutation appears in approximately 20-30% of AML patients and are associated with high risk, high relapse rates and poor clinical outcome. The type I selective second-generation oral inhibitor, gilteritinib, received initial global approval for use to treat adults with relapsed or refractory (R/R) FLT3 ITD positive AML in Japan in September 2018. Based on interim results of the ADMIRAL trail (Perl AE, et al., 2019), the FDA approved the drug for treatment of adult R/R AML with FLT3 ITD mutations in November 2018. The FDA approved companion diagnostic, LeukoStrat CDx FLT3 Mutation assay. NCCN AML guidelines classify gilteritinib as a category 1 recommendation for R/R AML patients harboring FLT3 ITD.",
                        "gene_id": 24,
                        "variant_id": 55,
                        "disease": {
                            "id": 3,
                            "name": "Acute Myeloid Leukemia",
                            "display_name": "Acute Myeloid Leukemia",
                            "doid": "9119",
                            "disease_url": "http://www.disease-ontology.org/?id=DOID:9119"
                        },
                        "drugs": [
                            {
                                "id": 641,
                                "name": "Gilteritinib",
                                "ncit_id": "C116722",
                                "aliases": [
                                    "Xospata",
                                    "ASP2215",
                                    "ASP-2215",
                                    "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide"
                                ]
                            }
                        ],
                        "evidence_type": "Predictive",
                        "evidence_direction": "Supports",
                        "clinical_significance": "Sensitivity/Response",
                        "evidence_item_count": 4,
                        "fda_regulatory_approval": true,
                        "status": "accepted",
                        "open_change_count": 0,
                        "pending_evidence_count": 0,
                        "flagged": false,
                        "updated_at": "2020-12-03T04:02:19.779Z"
                    }
                ],
                "errors": {},
                "lifecycle_actions": {
                    "submitted": {
                        "timestamp": "2019-11-07T09:47:05.221Z",
                        "user": {
                            "id": 100,
                            "name": "Damian Rieke",
                            "last_seen_at": "2021-01-14T14:43:10.872Z",
                            "username": "DamianRieke",
                            "role": "editor",
                            "avatar_url": "https://secure.gravatar.com/avatar/baaffa3938cc82f434ca5561e34d3de9.png?d=identicon\u0026r=pg\u0026s=32",
                            "avatars": {
                                "x128": "https://secure.gravatar.com/avatar/baaffa3938cc82f434ca5561e34d3de9.png?d=identicon\u0026r=pg\u0026s=128",
                                "x64": "https://secure.gravatar.com/avatar/baaffa3938cc82f434ca5561e34d3de9.png?d=identicon\u0026r=pg\u0026s=64",
                                "x32": "https://secure.gravatar.com/avatar/baaffa3938cc82f434ca5561e34d3de9.png?d=identicon\u0026r=pg\u0026s=32",
                                "x14": "https://secure.gravatar.com/avatar/baaffa3938cc82f434ca5561e34d3de9.png?d=identicon\u0026r=pg\u0026s=14"
                            },
                            "area_of_expertise": "Clinical Scientist",
                            "orcid": "0000-0003-0027-7977",
                            "display_name": "DamianRieke",
                            "created_at": "2015-12-14T08:37:49.264Z",
                            "url": "https://cccc.charite.de",
                            "twitter_handle": "",
                            "facebook_profile": "",
                            "linkedin_profile": "",
                            "bio": "Damian Rieke is a physician and researcher at the Charité Comprehensive Cancer Center and the Department for Hematology, Oncology and Tumor Immunology at Charité - University Medicine Berlin in Berlin, Germany. His main areas of interest include the development of targeted therapy strategies and the targeted use of immune therapeutics as well as their application in clinic.",
                            "country": {
                                "id": 74,
                                "iso": "DE",
                                "name": "Germany"
                            },
                            "featured_expert": true,
                            "accepted_license": null,
                            "signup_complete": null,
                            "organizations": [
                                {
                                    "id": 5,
                                    "name": "The Charité Comprehensive Cancer Center",
                                    "url": "https://cccc.charite.de/en/",
                                    "description": "Charité – Universitätsmedizin Berlin in Berlin, Germany is one of the largest university hospitals in Europe. The Charité Comprehensive Cancer Center is dedicated to integrating medical, psychological and social care as well as preclinical and clinical research to improve therapies for tumor patients. In collaboration with CIViC, the Charité Comprehensive Cancer Center translates genomic data into therapy, aiming to improve personalized oncology and advance its application in clinical routine.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/005/x256/charite-org.png?1592507820",
                                        "x128": "/system/organizations/profile_images/000/000/005/x128/charite-org.png?1592507820",
                                        "x64": "/system/organizations/profile_images/000/000/005/x64/charite-org.png?1592507820",
                                        "x32": "/system/organizations/profile_images/000/000/005/x32/charite-org.png?1592507820",
                                        "x14": "/system/organizations/profile_images/000/000/005/x14/charite-org.png?1592507820"
                                    },
                                    "parent": {}
                                }
                            ],
                            "most_recent_organization": {
                                "id": 5,
                                "name": "The Charité Comprehensive Cancer Center",
                                "url": "https://cccc.charite.de/en/",
                                "description": "Charité – Universitätsmedizin Berlin in Berlin, Germany is one of the largest university hospitals in Europe. The Charité Comprehensive Cancer Center is dedicated to integrating medical, psychological and social care as well as preclinical and clinical research to improve therapies for tumor patients. In collaboration with CIViC, the Charité Comprehensive Cancer Center translates genomic data into therapy, aiming to improve personalized oncology and advance its application in clinical routine.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/005/x256/charite-org.png?1592507820",
                                    "x128": "/system/organizations/profile_images/000/000/005/x128/charite-org.png?1592507820",
                                    "x64": "/system/organizations/profile_images/000/000/005/x64/charite-org.png?1592507820",
                                    "x32": "/system/organizations/profile_images/000/000/005/x32/charite-org.png?1592507820",
                                    "x14": "/system/organizations/profile_images/000/000/005/x14/charite-org.png?1592507820"
                                },
                                "parent": {}
                            },
                            "conflict_of_interest": {
                                "coi_valid": "conflict",
                                "details": {
                                    "coi_present": true,
                                    "coi_statement": "Consulting: Alacris Theranostics\nHonoraria: Bristol-Myers Squibb, Bayer",
                                    "created_at": "2020-11-18T09:39:45.421Z",
                                    "expires_at": "2021-11-18T09:39:45.421Z"
                                }
                            }
                        },
                        "organization": {
                            "id": 5,
                            "name": "The Charité Comprehensive Cancer Center",
                            "url": "https://cccc.charite.de/en/",
                            "description": "Charité – Universitätsmedizin Berlin in Berlin, Germany is one of the largest university hospitals in Europe. The Charité Comprehensive Cancer Center is dedicated to integrating medical, psychological and social care as well as preclinical and clinical research to improve therapies for tumor patients. In collaboration with CIViC, the Charité Comprehensive Cancer Center translates genomic data into therapy, aiming to improve personalized oncology and advance its application in clinical routine.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/005/x256/charite-org.png?1592507820",
                                "x128": "/system/organizations/profile_images/000/000/005/x128/charite-org.png?1592507820",
                                "x64": "/system/organizations/profile_images/000/000/005/x64/charite-org.png?1592507820",
                                "x32": "/system/organizations/profile_images/000/000/005/x32/charite-org.png?1592507820",
                                "x14": "/system/organizations/profile_images/000/000/005/x14/charite-org.png?1592507820"
                            },
                            "parent": {}
                        }
                    },
                    "last_modified": {
                        "timestamp": "2020-07-13T20:10:49.873Z",
                        "user": {
                            "id": 1053,
                            "name": "Jason Saliba",
                            "last_seen_at": "2021-02-02T09:04:58.553Z",
                            "username": "JasonSaliba",
                            "role": "admin",
                            "avatar_url": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=32",
                            "avatars": {
                                "x128": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=128",
                                "x64": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=64",
                                "x32": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=32",
                                "x14": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=14"
                            },
                            "area_of_expertise": "Research Scientist",
                            "orcid": "0000-0003-3035-2296",
                            "display_name": "JasonSaliba",
                            "created_at": "2020-01-07T17:53:13.677Z",
                            "url": "",
                            "twitter_handle": "jasonmsaliba",
                            "facebook_profile": "",
                            "linkedin_profile": "",
                            "bio": "Dr. Saliba is a Senior Scientist in the Griffith Lab at the Washington University School of Medicine. He received his PhD in Molecular and Human Genetics from Baylor College of Medicine. During his training, he studied germline susceptibility genes and somatic relapse drivers in pediatric leukemia with a special interest in pharmacogenetics. His primary focus is the editorial maintenance of CIViC along with driving the evolution of the knowledgebase and fostering enhancements through training and collaborations.",
                            "country": {
                                "id": 214,
                                "iso": "US",
                                "name": "United States"
                            },
                            "featured_expert": false,
                            "accepted_license": null,
                            "signup_complete": null,
                            "organizations": [
                                {
                                    "id": 12,
                                    "name": "Washington University in Saint Louis",
                                    "url": "https://wustl.edu/",
                                    "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                        "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                        "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                        "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                        "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                    },
                                    "parent": {}
                                },
                                {
                                    "id": 9,
                                    "name": "Pediatric Cancer Task Force",
                                    "url": "https://www.clinicalgenome.org/working-groups/somatic/pediatric-task-team/\r\n",
                                    "description": "Pediatric Cancer Task Force within the ClinGen Somatic Work Group focuses on curation of clinically relevant somatic variants in pediatric cancers. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/009/x256/clingen-vcep-1.png?1596737215",
                                        "x128": "/system/organizations/profile_images/000/000/009/x128/clingen-vcep-1.png?1596737215",
                                        "x64": "/system/organizations/profile_images/000/000/009/x64/clingen-vcep-1.png?1596737215",
                                        "x32": "/system/organizations/profile_images/000/000/009/x32/clingen-vcep-1.png?1596737215",
                                        "x14": "/system/organizations/profile_images/000/000/009/x14/clingen-vcep-1.png?1596737215"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 1,
                                    "name": "The McDonnell Genome Institute",
                                    "url": "http://genome.wustl.edu/",
                                    "description": "The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/001/x256/mgi-org.png?1592507909",
                                        "x128": "/system/organizations/profile_images/000/000/001/x128/mgi-org.png?1592507909",
                                        "x64": "/system/organizations/profile_images/000/000/001/x64/mgi-org.png?1592507909",
                                        "x32": "/system/organizations/profile_images/000/000/001/x32/mgi-org.png?1592507909",
                                        "x14": "/system/organizations/profile_images/000/000/001/x14/mgi-org.png?1592507909"
                                    },
                                    "parent": {
                                        "id": 12,
                                        "name": "Washington University in Saint Louis",
                                        "url": "https://wustl.edu/",
                                        "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                            "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                            "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                            "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                            "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 13,
                                    "name": "Genitourinary Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/genitourinary-cancer/",
                                    "description": "The Genitourinary Cancer Taskforce will embark on variant curation for FGFR and AR genes, using Clinical Interpretations of Variants in Cancer (CIViC) platform for variant curation.  The somatic variants should be examined and curated for the clinical significance/clinical management of patients, i.e. their role in the diagnosis, prognosis, therapeutic outcomes, prevention of the disease, or disease surveillance.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/013/x256/clingen-vcep-6.png?1596737087",
                                        "x128": "/system/organizations/profile_images/000/000/013/x128/clingen-vcep-6.png?1596737087",
                                        "x64": "/system/organizations/profile_images/000/000/013/x64/clingen-vcep-6.png?1596737087",
                                        "x32": "/system/organizations/profile_images/000/000/013/x32/clingen-vcep-6.png?1596737087",
                                        "x14": "/system/organizations/profile_images/000/000/013/x14/clingen-vcep-6.png?1596737087"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 11,
                                    "name": "Hematologic Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                                    "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                        "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                        "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                        "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                        "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 14,
                                    "name": "NTRK VCEP",
                                    "url": "",
                                    "description": "The ClinGen NTRK expert panel will develop a sustainable process for systematic consensus review of fusions and associated secondary alterations in NTRK1, NTRK2, and NTRK3 genes that drive oncogenesis and response to targeted therapy. The group will focus on further specifying and piloting the AMP/ASCO/CAP guidelines (PMID: 27993330) for somatic variant classification and the diagnostic and therapeutic significance of NTRK fusions in cancers. After consensus classification, the panel will make these interpretations publicly available through the CIViC knowledgebase.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/014/x256/clingen-vcep-2.png?1596737246",
                                        "x128": "/system/organizations/profile_images/000/000/014/x128/clingen-vcep-2.png?1596737246",
                                        "x64": "/system/organizations/profile_images/000/000/014/x64/clingen-vcep-2.png?1596737246",
                                        "x32": "/system/organizations/profile_images/000/000/014/x32/clingen-vcep-2.png?1596737246",
                                        "x14": "/system/organizations/profile_images/000/000/014/x14/clingen-vcep-2.png?1596737246"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                }
                            ],
                            "most_recent_organization": {
                                "id": 1,
                                "name": "The McDonnell Genome Institute",
                                "url": "http://genome.wustl.edu/",
                                "description": "The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/001/x256/mgi-org.png?1592507909",
                                    "x128": "/system/organizations/profile_images/000/000/001/x128/mgi-org.png?1592507909",
                                    "x64": "/system/organizations/profile_images/000/000/001/x64/mgi-org.png?1592507909",
                                    "x32": "/system/organizations/profile_images/000/000/001/x32/mgi-org.png?1592507909",
                                    "x14": "/system/organizations/profile_images/000/000/001/x14/mgi-org.png?1592507909"
                                },
                                "parent": {
                                    "id": 12,
                                    "name": "Washington University in Saint Louis",
                                    "url": "https://wustl.edu/",
                                    "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                        "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                        "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                        "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                        "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                    },
                                    "parent": {}
                                }
                            },
                            "conflict_of_interest": {
                                "coi_valid": "valid",
                                "details": {
                                    "coi_present": false,
                                    "coi_statement": "",
                                    "created_at": "2020-05-08T15:59:47.263Z",
                                    "expires_at": "2021-05-08T15:59:47.263Z"
                                }
                            }
                        },
                        "organization": {
                            "id": 1,
                            "name": "The McDonnell Genome Institute",
                            "url": "http://genome.wustl.edu/",
                            "description": "The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/001/x256/mgi-org.png?1592507909",
                                "x128": "/system/organizations/profile_images/000/000/001/x128/mgi-org.png?1592507909",
                                "x64": "/system/organizations/profile_images/000/000/001/x64/mgi-org.png?1592507909",
                                "x32": "/system/organizations/profile_images/000/000/001/x32/mgi-org.png?1592507909",
                                "x14": "/system/organizations/profile_images/000/000/001/x14/mgi-org.png?1592507909"
                            },
                            "parent": {
                                "id": 12,
                                "name": "Washington University in Saint Louis",
                                "url": "https://wustl.edu/",
                                "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                    "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                    "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                    "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                    "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                },
                                "parent": {}
                            }
                        }
                    },
                    "last_reviewed": {
                        "timestamp": "2020-07-14T01:21:25.799Z",
                        "user": {
                            "id": 341,
                            "name": "Shruti Rao",
                            "last_seen_at": "2021-01-29T17:35:11.856Z",
                            "username": "ShrutiRao",
                            "role": "editor",
                            "avatar_url": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=32",
                            "avatars": {
                                "x128": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=128",
                                "x64": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=64",
                                "x32": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=32",
                                "x14": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=14"
                            },
                            "area_of_expertise": "Research Scientist",
                            "orcid": "0000-0002-7235-0777",
                            "display_name": "ShrutiRao",
                            "created_at": "2017-02-02T15:43:46.594Z",
                            "url": "",
                            "twitter_handle": "",
                            "facebook_profile": "",
                            "linkedin_profile": "https://www.linkedin.com/in/shrutiarao/",
                            "bio": "",
                            "country": {
                                "id": 214,
                                "iso": "US",
                                "name": "United States"
                            },
                            "featured_expert": false,
                            "accepted_license": null,
                            "signup_complete": null,
                            "organizations": [
                                {
                                    "id": 9,
                                    "name": "Pediatric Cancer Task Force",
                                    "url": "https://www.clinicalgenome.org/working-groups/somatic/pediatric-task-team/\r\n",
                                    "description": "Pediatric Cancer Task Force within the ClinGen Somatic Work Group focuses on curation of clinically relevant somatic variants in pediatric cancers. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/009/x256/clingen-vcep-1.png?1596737215",
                                        "x128": "/system/organizations/profile_images/000/000/009/x128/clingen-vcep-1.png?1596737215",
                                        "x64": "/system/organizations/profile_images/000/000/009/x64/clingen-vcep-1.png?1596737215",
                                        "x32": "/system/organizations/profile_images/000/000/009/x32/clingen-vcep-1.png?1596737215",
                                        "x14": "/system/organizations/profile_images/000/000/009/x14/clingen-vcep-1.png?1596737215"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 2,
                                    "name": "ClinGen",
                                    "url": "https://www.clinicalgenome.org/",
                                    "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                        "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                        "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                        "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                        "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                    },
                                    "parent": {}
                                },
                                {
                                    "id": 13,
                                    "name": "Genitourinary Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/genitourinary-cancer/",
                                    "description": "The Genitourinary Cancer Taskforce will embark on variant curation for FGFR and AR genes, using Clinical Interpretations of Variants in Cancer (CIViC) platform for variant curation.  The somatic variants should be examined and curated for the clinical significance/clinical management of patients, i.e. their role in the diagnosis, prognosis, therapeutic outcomes, prevention of the disease, or disease surveillance.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/013/x256/clingen-vcep-6.png?1596737087",
                                        "x128": "/system/organizations/profile_images/000/000/013/x128/clingen-vcep-6.png?1596737087",
                                        "x64": "/system/organizations/profile_images/000/000/013/x64/clingen-vcep-6.png?1596737087",
                                        "x32": "/system/organizations/profile_images/000/000/013/x32/clingen-vcep-6.png?1596737087",
                                        "x14": "/system/organizations/profile_images/000/000/013/x14/clingen-vcep-6.png?1596737087"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 11,
                                    "name": "Hematologic Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                                    "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                        "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                        "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                        "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                        "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 14,
                                    "name": "NTRK VCEP",
                                    "url": "",
                                    "description": "The ClinGen NTRK expert panel will develop a sustainable process for systematic consensus review of fusions and associated secondary alterations in NTRK1, NTRK2, and NTRK3 genes that drive oncogenesis and response to targeted therapy. The group will focus on further specifying and piloting the AMP/ASCO/CAP guidelines (PMID: 27993330) for somatic variant classification and the diagnostic and therapeutic significance of NTRK fusions in cancers. After consensus classification, the panel will make these interpretations publicly available through the CIViC knowledgebase.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/014/x256/clingen-vcep-2.png?1596737246",
                                        "x128": "/system/organizations/profile_images/000/000/014/x128/clingen-vcep-2.png?1596737246",
                                        "x64": "/system/organizations/profile_images/000/000/014/x64/clingen-vcep-2.png?1596737246",
                                        "x32": "/system/organizations/profile_images/000/000/014/x32/clingen-vcep-2.png?1596737246",
                                        "x14": "/system/organizations/profile_images/000/000/014/x14/clingen-vcep-2.png?1596737246"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                }
                            ],
                            "most_recent_organization": {
                                "id": 11,
                                "name": "Hematologic Cancer Taskforce",
                                "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                                "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                    "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                    "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                    "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                    "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                                },
                                "parent": {
                                    "id": 2,
                                    "name": "ClinGen",
                                    "url": "https://www.clinicalgenome.org/",
                                    "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                        "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                        "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                        "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                        "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                    },
                                    "parent": {}
                                }
                            },
                            "conflict_of_interest": {
                                "coi_valid": "valid",
                                "details": {
                                    "coi_present": false,
                                    "coi_statement": "",
                                    "created_at": "2020-12-04T16:49:52.232Z",
                                    "expires_at": "2021-12-04T16:49:52.232Z"
                                }
                            }
                        },
                        "organization": {
                            "id": 2,
                            "name": "ClinGen",
                            "url": "https://www.clinicalgenome.org/",
                            "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                            },
                            "parent": {}
                        }
                    },
                    "last_commented_on": {
                        "timestamp": "2021-01-20T20:46:06.278Z",
                        "user": {
                            "id": 341,
                            "name": "Shruti Rao",
                            "last_seen_at": "2021-01-29T17:35:11.856Z",
                            "username": "ShrutiRao",
                            "role": "editor",
                            "avatar_url": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=32",
                            "avatars": {
                                "x128": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=128",
                                "x64": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=64",
                                "x32": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=32",
                                "x14": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=14"
                            },
                            "area_of_expertise": "Research Scientist",
                            "orcid": "0000-0002-7235-0777",
                            "display_name": "ShrutiRao",
                            "created_at": "2017-02-02T15:43:46.594Z",
                            "url": "",
                            "twitter_handle": "",
                            "facebook_profile": "",
                            "linkedin_profile": "https://www.linkedin.com/in/shrutiarao/",
                            "bio": "",
                            "country": {
                                "id": 214,
                                "iso": "US",
                                "name": "United States"
                            },
                            "featured_expert": false,
                            "accepted_license": null,
                            "signup_complete": null,
                            "organizations": [
                                {
                                    "id": 9,
                                    "name": "Pediatric Cancer Task Force",
                                    "url": "https://www.clinicalgenome.org/working-groups/somatic/pediatric-task-team/\r\n",
                                    "description": "Pediatric Cancer Task Force within the ClinGen Somatic Work Group focuses on curation of clinically relevant somatic variants in pediatric cancers. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/009/x256/clingen-vcep-1.png?1596737215",
                                        "x128": "/system/organizations/profile_images/000/000/009/x128/clingen-vcep-1.png?1596737215",
                                        "x64": "/system/organizations/profile_images/000/000/009/x64/clingen-vcep-1.png?1596737215",
                                        "x32": "/system/organizations/profile_images/000/000/009/x32/clingen-vcep-1.png?1596737215",
                                        "x14": "/system/organizations/profile_images/000/000/009/x14/clingen-vcep-1.png?1596737215"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 2,
                                    "name": "ClinGen",
                                    "url": "https://www.clinicalgenome.org/",
                                    "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                        "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                        "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                        "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                        "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                    },
                                    "parent": {}
                                },
                                {
                                    "id": 13,
                                    "name": "Genitourinary Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/genitourinary-cancer/",
                                    "description": "The Genitourinary Cancer Taskforce will embark on variant curation for FGFR and AR genes, using Clinical Interpretations of Variants in Cancer (CIViC) platform for variant curation.  The somatic variants should be examined and curated for the clinical significance/clinical management of patients, i.e. their role in the diagnosis, prognosis, therapeutic outcomes, prevention of the disease, or disease surveillance.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/013/x256/clingen-vcep-6.png?1596737087",
                                        "x128": "/system/organizations/profile_images/000/000/013/x128/clingen-vcep-6.png?1596737087",
                                        "x64": "/system/organizations/profile_images/000/000/013/x64/clingen-vcep-6.png?1596737087",
                                        "x32": "/system/organizations/profile_images/000/000/013/x32/clingen-vcep-6.png?1596737087",
                                        "x14": "/system/organizations/profile_images/000/000/013/x14/clingen-vcep-6.png?1596737087"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 11,
                                    "name": "Hematologic Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                                    "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                        "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                        "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                        "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                        "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 14,
                                    "name": "NTRK VCEP",
                                    "url": "",
                                    "description": "The ClinGen NTRK expert panel will develop a sustainable process for systematic consensus review of fusions and associated secondary alterations in NTRK1, NTRK2, and NTRK3 genes that drive oncogenesis and response to targeted therapy. The group will focus on further specifying and piloting the AMP/ASCO/CAP guidelines (PMID: 27993330) for somatic variant classification and the diagnostic and therapeutic significance of NTRK fusions in cancers. After consensus classification, the panel will make these interpretations publicly available through the CIViC knowledgebase.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/014/x256/clingen-vcep-2.png?1596737246",
                                        "x128": "/system/organizations/profile_images/000/000/014/x128/clingen-vcep-2.png?1596737246",
                                        "x64": "/system/organizations/profile_images/000/000/014/x64/clingen-vcep-2.png?1596737246",
                                        "x32": "/system/organizations/profile_images/000/000/014/x32/clingen-vcep-2.png?1596737246",
                                        "x14": "/system/organizations/profile_images/000/000/014/x14/clingen-vcep-2.png?1596737246"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                }
                            ],
                            "most_recent_organization": {
                                "id": 11,
                                "name": "Hematologic Cancer Taskforce",
                                "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                                "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                    "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                    "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                    "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                    "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                                },
                                "parent": {
                                    "id": 2,
                                    "name": "ClinGen",
                                    "url": "https://www.clinicalgenome.org/",
                                    "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                        "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                        "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                        "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                        "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                    },
                                    "parent": {}
                                }
                            },
                            "conflict_of_interest": {
                                "coi_valid": "valid",
                                "details": {
                                    "coi_present": false,
                                    "coi_statement": "",
                                    "created_at": "2020-12-04T16:49:52.232Z",
                                    "expires_at": "2021-12-04T16:49:52.232Z"
                                }
                            }
                        },
                        "organization": {
                            "id": 11,
                            "name": "Hematologic Cancer Taskforce",
                            "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                            "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                            },
                            "parent": {
                                "id": 2,
                                "name": "ClinGen",
                                "url": "https://www.clinicalgenome.org/",
                                "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                    "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                    "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                    "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                    "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                },
                                "parent": {}
                            }
                        }
                    },
                    "accepted": {
                        "timestamp": "2020-07-13T20:08:51.226Z",
                        "user": {
                            "id": 1053,
                            "name": "Jason Saliba",
                            "last_seen_at": "2021-02-02T09:04:58.553Z",
                            "username": "JasonSaliba",
                            "role": "admin",
                            "avatar_url": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=32",
                            "avatars": {
                                "x128": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=128",
                                "x64": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=64",
                                "x32": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=32",
                                "x14": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=14"
                            },
                            "area_of_expertise": "Research Scientist",
                            "orcid": "0000-0003-3035-2296",
                            "display_name": "JasonSaliba",
                            "created_at": "2020-01-07T17:53:13.677Z",
                            "url": "",
                            "twitter_handle": "jasonmsaliba",
                            "facebook_profile": "",
                            "linkedin_profile": "",
                            "bio": "Dr. Saliba is a Senior Scientist in the Griffith Lab at the Washington University School of Medicine. He received his PhD in Molecular and Human Genetics from Baylor College of Medicine. During his training, he studied germline susceptibility genes and somatic relapse drivers in pediatric leukemia with a special interest in pharmacogenetics. His primary focus is the editorial maintenance of CIViC along with driving the evolution of the knowledgebase and fostering enhancements through training and collaborations.",
                            "country": {
                                "id": 214,
                                "iso": "US",
                                "name": "United States"
                            },
                            "featured_expert": false,
                            "accepted_license": null,
                            "signup_complete": null,
                            "organizations": [
                                {
                                    "id": 12,
                                    "name": "Washington University in Saint Louis",
                                    "url": "https://wustl.edu/",
                                    "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                        "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                        "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                        "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                        "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                    },
                                    "parent": {}
                                },
                                {
                                    "id": 9,
                                    "name": "Pediatric Cancer Task Force",
                                    "url": "https://www.clinicalgenome.org/working-groups/somatic/pediatric-task-team/\r\n",
                                    "description": "Pediatric Cancer Task Force within the ClinGen Somatic Work Group focuses on curation of clinically relevant somatic variants in pediatric cancers. ",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/009/x256/clingen-vcep-1.png?1596737215",
                                        "x128": "/system/organizations/profile_images/000/000/009/x128/clingen-vcep-1.png?1596737215",
                                        "x64": "/system/organizations/profile_images/000/000/009/x64/clingen-vcep-1.png?1596737215",
                                        "x32": "/system/organizations/profile_images/000/000/009/x32/clingen-vcep-1.png?1596737215",
                                        "x14": "/system/organizations/profile_images/000/000/009/x14/clingen-vcep-1.png?1596737215"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 1,
                                    "name": "The McDonnell Genome Institute",
                                    "url": "http://genome.wustl.edu/",
                                    "description": "The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/001/x256/mgi-org.png?1592507909",
                                        "x128": "/system/organizations/profile_images/000/000/001/x128/mgi-org.png?1592507909",
                                        "x64": "/system/organizations/profile_images/000/000/001/x64/mgi-org.png?1592507909",
                                        "x32": "/system/organizations/profile_images/000/000/001/x32/mgi-org.png?1592507909",
                                        "x14": "/system/organizations/profile_images/000/000/001/x14/mgi-org.png?1592507909"
                                    },
                                    "parent": {
                                        "id": 12,
                                        "name": "Washington University in Saint Louis",
                                        "url": "https://wustl.edu/",
                                        "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                            "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                            "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                            "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                            "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 13,
                                    "name": "Genitourinary Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/genitourinary-cancer/",
                                    "description": "The Genitourinary Cancer Taskforce will embark on variant curation for FGFR and AR genes, using Clinical Interpretations of Variants in Cancer (CIViC) platform for variant curation.  The somatic variants should be examined and curated for the clinical significance/clinical management of patients, i.e. their role in the diagnosis, prognosis, therapeutic outcomes, prevention of the disease, or disease surveillance.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/013/x256/clingen-vcep-6.png?1596737087",
                                        "x128": "/system/organizations/profile_images/000/000/013/x128/clingen-vcep-6.png?1596737087",
                                        "x64": "/system/organizations/profile_images/000/000/013/x64/clingen-vcep-6.png?1596737087",
                                        "x32": "/system/organizations/profile_images/000/000/013/x32/clingen-vcep-6.png?1596737087",
                                        "x14": "/system/organizations/profile_images/000/000/013/x14/clingen-vcep-6.png?1596737087"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 11,
                                    "name": "Hematologic Cancer Taskforce",
                                    "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                                    "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                        "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                        "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                        "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                        "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                },
                                {
                                    "id": 14,
                                    "name": "NTRK VCEP",
                                    "url": "",
                                    "description": "The ClinGen NTRK expert panel will develop a sustainable process for systematic consensus review of fusions and associated secondary alterations in NTRK1, NTRK2, and NTRK3 genes that drive oncogenesis and response to targeted therapy. The group will focus on further specifying and piloting the AMP/ASCO/CAP guidelines (PMID: 27993330) for somatic variant classification and the diagnostic and therapeutic significance of NTRK fusions in cancers. After consensus classification, the panel will make these interpretations publicly available through the CIViC knowledgebase.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/014/x256/clingen-vcep-2.png?1596737246",
                                        "x128": "/system/organizations/profile_images/000/000/014/x128/clingen-vcep-2.png?1596737246",
                                        "x64": "/system/organizations/profile_images/000/000/014/x64/clingen-vcep-2.png?1596737246",
                                        "x32": "/system/organizations/profile_images/000/000/014/x32/clingen-vcep-2.png?1596737246",
                                        "x14": "/system/organizations/profile_images/000/000/014/x14/clingen-vcep-2.png?1596737246"
                                    },
                                    "parent": {
                                        "id": 2,
                                        "name": "ClinGen",
                                        "url": "https://www.clinicalgenome.org/",
                                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                        "profile_image": {
                                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                        },
                                        "parent": {}
                                    }
                                }
                            ],
                            "most_recent_organization": {
                                "id": 1,
                                "name": "The McDonnell Genome Institute",
                                "url": "http://genome.wustl.edu/",
                                "description": "The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/001/x256/mgi-org.png?1592507909",
                                    "x128": "/system/organizations/profile_images/000/000/001/x128/mgi-org.png?1592507909",
                                    "x64": "/system/organizations/profile_images/000/000/001/x64/mgi-org.png?1592507909",
                                    "x32": "/system/organizations/profile_images/000/000/001/x32/mgi-org.png?1592507909",
                                    "x14": "/system/organizations/profile_images/000/000/001/x14/mgi-org.png?1592507909"
                                },
                                "parent": {
                                    "id": 12,
                                    "name": "Washington University in Saint Louis",
                                    "url": "https://wustl.edu/",
                                    "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                    "profile_image": {
                                        "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                        "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                        "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                        "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                        "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                    },
                                    "parent": {}
                                }
                            },
                            "conflict_of_interest": {
                                "coi_valid": "valid",
                                "details": {
                                    "coi_present": false,
                                    "coi_statement": "",
                                    "created_at": "2020-05-08T15:59:47.263Z",
                                    "expires_at": "2021-05-08T15:59:47.263Z"
                                }
                            }
                        },
                        "organization": {
                            "id": 1,
                            "name": "The McDonnell Genome Institute",
                            "url": "http://genome.wustl.edu/",
                            "description": "The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/001/x256/mgi-org.png?1592507909",
                                "x128": "/system/organizations/profile_images/000/000/001/x128/mgi-org.png?1592507909",
                                "x64": "/system/organizations/profile_images/000/000/001/x64/mgi-org.png?1592507909",
                                "x32": "/system/organizations/profile_images/000/000/001/x32/mgi-org.png?1592507909",
                                "x14": "/system/organizations/profile_images/000/000/001/x14/mgi-org.png?1592507909"
                            },
                            "parent": {
                                "id": 12,
                                "name": "Washington University in Saint Louis",
                                "url": "https://wustl.edu/",
                                "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                    "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                    "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                    "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                    "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                },
                                "parent": {}
                            }
                        }
                    }
                },
                "fields_with_pending_changes": {},
                "gene_id": 24,
                "state_params": {
                    "evidence_item": {
                        "id": 7728,
                        "name": "EID7728"
                    },
                    "variant": {
                        "id": 519,
                        "name": "MUTATION"
                    },
                    "gene": {
                        "id": 24,
                        "name": "FLT3"
                    }
                }
            }
        ],
        "acmg_codes": [],
        "drug_interaction_type": null,
        "fda_companion_test": true,
        "allele_registry_id": null,
        "phenotypes": [],
        "variant_origin": "Somatic",
        "lifecycle_actions": {
            "submitted": {
                "timestamp": "2020-11-18T23:03:32.495Z",
                "user": {
                    "id": 341,
                    "name": "Shruti Rao",
                    "last_seen_at": "2021-01-29T17:35:11.856Z",
                    "username": "ShrutiRao",
                    "role": "editor",
                    "avatar_url": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=32",
                    "avatars": {
                        "x128": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=128",
                        "x64": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=64",
                        "x32": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=32",
                        "x14": "https://secure.gravatar.com/avatar/82ba3259112dd3afaa9dd027db2955fd.png?d=identicon\u0026r=pg\u0026s=14"
                    },
                    "area_of_expertise": "Research Scientist",
                    "orcid": "0000-0002-7235-0777",
                    "display_name": "ShrutiRao",
                    "created_at": "2017-02-02T15:43:46.594Z",
                    "url": "",
                    "twitter_handle": "",
                    "facebook_profile": "",
                    "linkedin_profile": "https://www.linkedin.com/in/shrutiarao/",
                    "bio": "",
                    "country": {
                        "id": 214,
                        "iso": "US",
                        "name": "United States"
                    },
                    "featured_expert": false,
                    "accepted_license": null,
                    "signup_complete": null,
                    "organizations": [
                        {
                            "id": 9,
                            "name": "Pediatric Cancer Task Force",
                            "url": "https://www.clinicalgenome.org/working-groups/somatic/pediatric-task-team/\r\n",
                            "description": "Pediatric Cancer Task Force within the ClinGen Somatic Work Group focuses on curation of clinically relevant somatic variants in pediatric cancers. ",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/009/x256/clingen-vcep-1.png?1596737215",
                                "x128": "/system/organizations/profile_images/000/000/009/x128/clingen-vcep-1.png?1596737215",
                                "x64": "/system/organizations/profile_images/000/000/009/x64/clingen-vcep-1.png?1596737215",
                                "x32": "/system/organizations/profile_images/000/000/009/x32/clingen-vcep-1.png?1596737215",
                                "x14": "/system/organizations/profile_images/000/000/009/x14/clingen-vcep-1.png?1596737215"
                            },
                            "parent": {
                                "id": 2,
                                "name": "ClinGen",
                                "url": "https://www.clinicalgenome.org/",
                                "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                    "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                    "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                    "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                    "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                },
                                "parent": {}
                            }
                        },
                        {
                            "id": 2,
                            "name": "ClinGen",
                            "url": "https://www.clinicalgenome.org/",
                            "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                            },
                            "parent": {}
                        },
                        {
                            "id": 13,
                            "name": "Genitourinary Cancer Taskforce",
                            "url": "https://clinicalgenome.org/working-groups/somatic/genitourinary-cancer/",
                            "description": "The Genitourinary Cancer Taskforce will embark on variant curation for FGFR and AR genes, using Clinical Interpretations of Variants in Cancer (CIViC) platform for variant curation.  The somatic variants should be examined and curated for the clinical significance/clinical management of patients, i.e. their role in the diagnosis, prognosis, therapeutic outcomes, prevention of the disease, or disease surveillance.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/013/x256/clingen-vcep-6.png?1596737087",
                                "x128": "/system/organizations/profile_images/000/000/013/x128/clingen-vcep-6.png?1596737087",
                                "x64": "/system/organizations/profile_images/000/000/013/x64/clingen-vcep-6.png?1596737087",
                                "x32": "/system/organizations/profile_images/000/000/013/x32/clingen-vcep-6.png?1596737087",
                                "x14": "/system/organizations/profile_images/000/000/013/x14/clingen-vcep-6.png?1596737087"
                            },
                            "parent": {
                                "id": 2,
                                "name": "ClinGen",
                                "url": "https://www.clinicalgenome.org/",
                                "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                    "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                    "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                    "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                    "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                },
                                "parent": {}
                            }
                        },
                        {
                            "id": 11,
                            "name": "Hematologic Cancer Taskforce",
                            "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                            "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                            },
                            "parent": {
                                "id": 2,
                                "name": "ClinGen",
                                "url": "https://www.clinicalgenome.org/",
                                "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                    "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                    "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                    "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                    "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                },
                                "parent": {}
                            }
                        },
                        {
                            "id": 14,
                            "name": "NTRK VCEP",
                            "url": "",
                            "description": "The ClinGen NTRK expert panel will develop a sustainable process for systematic consensus review of fusions and associated secondary alterations in NTRK1, NTRK2, and NTRK3 genes that drive oncogenesis and response to targeted therapy. The group will focus on further specifying and piloting the AMP/ASCO/CAP guidelines (PMID: 27993330) for somatic variant classification and the diagnostic and therapeutic significance of NTRK fusions in cancers. After consensus classification, the panel will make these interpretations publicly available through the CIViC knowledgebase.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/014/x256/clingen-vcep-2.png?1596737246",
                                "x128": "/system/organizations/profile_images/000/000/014/x128/clingen-vcep-2.png?1596737246",
                                "x64": "/system/organizations/profile_images/000/000/014/x64/clingen-vcep-2.png?1596737246",
                                "x32": "/system/organizations/profile_images/000/000/014/x32/clingen-vcep-2.png?1596737246",
                                "x14": "/system/organizations/profile_images/000/000/014/x14/clingen-vcep-2.png?1596737246"
                            },
                            "parent": {
                                "id": 2,
                                "name": "ClinGen",
                                "url": "https://www.clinicalgenome.org/",
                                "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                    "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                    "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                    "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                    "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                },
                                "parent": {}
                            }
                        }
                    ],
                    "most_recent_organization": {
                        "id": 11,
                        "name": "Hematologic Cancer Taskforce",
                        "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                        "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                        "profile_image": {
                            "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                            "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                            "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                            "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                            "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                        },
                        "parent": {
                            "id": 2,
                            "name": "ClinGen",
                            "url": "https://www.clinicalgenome.org/",
                            "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                            },
                            "parent": {}
                        }
                    },
                    "conflict_of_interest": {
                        "coi_valid": "valid",
                        "details": {
                            "coi_present": false,
                            "coi_statement": "",
                            "created_at": "2020-12-04T16:49:52.232Z",
                            "expires_at": "2021-12-04T16:49:52.232Z"
                        }
                    }
                },
                "organization": {
                    "id": 11,
                    "name": "Hematologic Cancer Taskforce",
                    "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                    "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                    "profile_image": {
                        "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                        "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                        "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                        "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                        "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                    },
                    "parent": {
                        "id": 2,
                        "name": "ClinGen",
                        "url": "https://www.clinicalgenome.org/",
                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                        "profile_image": {
                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                        },
                        "parent": {}
                    }
                }
            },
            "last_modified": {
                "timestamp": "2021-01-20T20:25:19.357Z",
                "user": {
                    "id": 1053,
                    "name": "Jason Saliba",
                    "last_seen_at": "2021-02-02T09:04:58.553Z",
                    "username": "JasonSaliba",
                    "role": "admin",
                    "avatar_url": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=32",
                    "avatars": {
                        "x128": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=128",
                        "x64": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=64",
                        "x32": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=32",
                        "x14": "https://secure.gravatar.com/avatar/d720de454f663128fc4926f5678a2fc8.png?d=identicon\u0026r=pg\u0026s=14"
                    },
                    "area_of_expertise": "Research Scientist",
                    "orcid": "0000-0003-3035-2296",
                    "display_name": "JasonSaliba",
                    "created_at": "2020-01-07T17:53:13.677Z",
                    "url": "",
                    "twitter_handle": "jasonmsaliba",
                    "facebook_profile": "",
                    "linkedin_profile": "",
                    "bio": "Dr. Saliba is a Senior Scientist in the Griffith Lab at the Washington University School of Medicine. He received his PhD in Molecular and Human Genetics from Baylor College of Medicine. During his training, he studied germline susceptibility genes and somatic relapse drivers in pediatric leukemia with a special interest in pharmacogenetics. His primary focus is the editorial maintenance of CIViC along with driving the evolution of the knowledgebase and fostering enhancements through training and collaborations.",
                    "country": {
                        "id": 214,
                        "iso": "US",
                        "name": "United States"
                    },
                    "featured_expert": false,
                    "accepted_license": null,
                    "signup_complete": null,
                    "organizations": [
                        {
                            "id": 12,
                            "name": "Washington University in Saint Louis",
                            "url": "https://wustl.edu/",
                            "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                            },
                            "parent": {}
                        },
                        {
                            "id": 9,
                            "name": "Pediatric Cancer Task Force",
                            "url": "https://www.clinicalgenome.org/working-groups/somatic/pediatric-task-team/\r\n",
                            "description": "Pediatric Cancer Task Force within the ClinGen Somatic Work Group focuses on curation of clinically relevant somatic variants in pediatric cancers. ",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/009/x256/clingen-vcep-1.png?1596737215",
                                "x128": "/system/organizations/profile_images/000/000/009/x128/clingen-vcep-1.png?1596737215",
                                "x64": "/system/organizations/profile_images/000/000/009/x64/clingen-vcep-1.png?1596737215",
                                "x32": "/system/organizations/profile_images/000/000/009/x32/clingen-vcep-1.png?1596737215",
                                "x14": "/system/organizations/profile_images/000/000/009/x14/clingen-vcep-1.png?1596737215"
                            },
                            "parent": {
                                "id": 2,
                                "name": "ClinGen",
                                "url": "https://www.clinicalgenome.org/",
                                "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                    "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                    "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                    "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                    "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                },
                                "parent": {}
                            }
                        },
                        {
                            "id": 1,
                            "name": "The McDonnell Genome Institute",
                            "url": "http://genome.wustl.edu/",
                            "description": "The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/001/x256/mgi-org.png?1592507909",
                                "x128": "/system/organizations/profile_images/000/000/001/x128/mgi-org.png?1592507909",
                                "x64": "/system/organizations/profile_images/000/000/001/x64/mgi-org.png?1592507909",
                                "x32": "/system/organizations/profile_images/000/000/001/x32/mgi-org.png?1592507909",
                                "x14": "/system/organizations/profile_images/000/000/001/x14/mgi-org.png?1592507909"
                            },
                            "parent": {
                                "id": 12,
                                "name": "Washington University in Saint Louis",
                                "url": "https://wustl.edu/",
                                "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                    "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                    "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                    "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                    "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                                },
                                "parent": {}
                            }
                        },
                        {
                            "id": 13,
                            "name": "Genitourinary Cancer Taskforce",
                            "url": "https://clinicalgenome.org/working-groups/somatic/genitourinary-cancer/",
                            "description": "The Genitourinary Cancer Taskforce will embark on variant curation for FGFR and AR genes, using Clinical Interpretations of Variants in Cancer (CIViC) platform for variant curation.  The somatic variants should be examined and curated for the clinical significance/clinical management of patients, i.e. their role in the diagnosis, prognosis, therapeutic outcomes, prevention of the disease, or disease surveillance.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/013/x256/clingen-vcep-6.png?1596737087",
                                "x128": "/system/organizations/profile_images/000/000/013/x128/clingen-vcep-6.png?1596737087",
                                "x64": "/system/organizations/profile_images/000/000/013/x64/clingen-vcep-6.png?1596737087",
                                "x32": "/system/organizations/profile_images/000/000/013/x32/clingen-vcep-6.png?1596737087",
                                "x14": "/system/organizations/profile_images/000/000/013/x14/clingen-vcep-6.png?1596737087"
                            },
                            "parent": {
                                "id": 2,
                                "name": "ClinGen",
                                "url": "https://www.clinicalgenome.org/",
                                "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                    "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                    "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                    "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                    "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                },
                                "parent": {}
                            }
                        },
                        {
                            "id": 11,
                            "name": "Hematologic Cancer Taskforce",
                            "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                            "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                                "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                                "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                                "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                                "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                            },
                            "parent": {
                                "id": 2,
                                "name": "ClinGen",
                                "url": "https://www.clinicalgenome.org/",
                                "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                    "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                    "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                    "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                    "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                },
                                "parent": {}
                            }
                        },
                        {
                            "id": 14,
                            "name": "NTRK VCEP",
                            "url": "",
                            "description": "The ClinGen NTRK expert panel will develop a sustainable process for systematic consensus review of fusions and associated secondary alterations in NTRK1, NTRK2, and NTRK3 genes that drive oncogenesis and response to targeted therapy. The group will focus on further specifying and piloting the AMP/ASCO/CAP guidelines (PMID: 27993330) for somatic variant classification and the diagnostic and therapeutic significance of NTRK fusions in cancers. After consensus classification, the panel will make these interpretations publicly available through the CIViC knowledgebase.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/014/x256/clingen-vcep-2.png?1596737246",
                                "x128": "/system/organizations/profile_images/000/000/014/x128/clingen-vcep-2.png?1596737246",
                                "x64": "/system/organizations/profile_images/000/000/014/x64/clingen-vcep-2.png?1596737246",
                                "x32": "/system/organizations/profile_images/000/000/014/x32/clingen-vcep-2.png?1596737246",
                                "x14": "/system/organizations/profile_images/000/000/014/x14/clingen-vcep-2.png?1596737246"
                            },
                            "parent": {
                                "id": 2,
                                "name": "ClinGen",
                                "url": "https://www.clinicalgenome.org/",
                                "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                                "profile_image": {
                                    "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                                    "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                                    "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                                    "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                                    "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                                },
                                "parent": {}
                            }
                        }
                    ],
                    "most_recent_organization": {
                        "id": 1,
                        "name": "The McDonnell Genome Institute",
                        "url": "http://genome.wustl.edu/",
                        "description": "The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.",
                        "profile_image": {
                            "x256": "/system/organizations/profile_images/000/000/001/x256/mgi-org.png?1592507909",
                            "x128": "/system/organizations/profile_images/000/000/001/x128/mgi-org.png?1592507909",
                            "x64": "/system/organizations/profile_images/000/000/001/x64/mgi-org.png?1592507909",
                            "x32": "/system/organizations/profile_images/000/000/001/x32/mgi-org.png?1592507909",
                            "x14": "/system/organizations/profile_images/000/000/001/x14/mgi-org.png?1592507909"
                        },
                        "parent": {
                            "id": 12,
                            "name": "Washington University in Saint Louis",
                            "url": "https://wustl.edu/",
                            "description": "Washington University in St. Louis’ mission is to discover and disseminate knowledge, and protect the freedom of inquiry through research, teaching and learning. Washington University creates an environment to encourage and support an ethos of wide-ranging exploration. Washington University’s faculty and staff strive to enhance the lives and livelihoods of students, the people of the greater St. Louis community, the country and the world.",
                            "profile_image": {
                                "x256": "/system/organizations/profile_images/000/000/012/x256/wustl-org.png?1592506215",
                                "x128": "/system/organizations/profile_images/000/000/012/x128/wustl-org.png?1592506215",
                                "x64": "/system/organizations/profile_images/000/000/012/x64/wustl-org.png?1592506215",
                                "x32": "/system/organizations/profile_images/000/000/012/x32/wustl-org.png?1592506215",
                                "x14": "/system/organizations/profile_images/000/000/012/x14/wustl-org.png?1592506215"
                            },
                            "parent": {}
                        }
                    },
                    "conflict_of_interest": {
                        "coi_valid": "valid",
                        "details": {
                            "coi_present": false,
                            "coi_statement": "",
                            "created_at": "2020-05-08T15:59:47.263Z",
                            "expires_at": "2021-05-08T15:59:47.263Z"
                        }
                    }
                },
                "organization": {
                    "id": 11,
                    "name": "Hematologic Cancer Taskforce",
                    "url": "https://clinicalgenome.org/working-groups/somatic/hematological-cancers/",
                    "description": "The Hematologic Cancer Taskforce within the ClinGen Somatic Work Group focuses on curation of clinically significant somatic variants in hematological malignancies.",
                    "profile_image": {
                        "x256": "/system/organizations/profile_images/000/000/011/x256/clingen-vcep-3.png?1596737121",
                        "x128": "/system/organizations/profile_images/000/000/011/x128/clingen-vcep-3.png?1596737121",
                        "x64": "/system/organizations/profile_images/000/000/011/x64/clingen-vcep-3.png?1596737121",
                        "x32": "/system/organizations/profile_images/000/000/011/x32/clingen-vcep-3.png?1596737121",
                        "x14": "/system/organizations/profile_images/000/000/011/x14/clingen-vcep-3.png?1596737121"
                    },
                    "parent": {
                        "id": 2,
                        "name": "ClinGen",
                        "url": "https://www.clinicalgenome.org/",
                        "description": "ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research. ",
                        "profile_image": {
                            "x256": "/system/organizations/profile_images/000/000/002/x256/clingen-parent.png?1592507884",
                            "x128": "/system/organizations/profile_images/000/000/002/x128/clingen-parent.png?1592507884",
                            "x64": "/system/organizations/profile_images/000/000/002/x64/clingen-parent.png?1592507884",
                            "x32": "/system/organizations/profile_images/000/000/002/x32/clingen-parent.png?1592507884",
                            "x14": "/system/organizations/profile_images/000/000/002/x14/clingen-parent.png?1592507884"
                        },
                        "parent": {}
                    }
                }
            }
        },
        "provisional_values": {
            "description": {
                "value": "Mutations in the FMS-like tyrosine kinase 3 (FLT3) gene are the most common mutations in acute myeloid leukemia (AML). Activating point mutations in the FLT3 tyrosine kinase domain (TKD) through autophosphorylation occur in 5 to 10% of AML and include the I836 residue. The type I selective second-generation oral inhibitor, gilteritinib, received FDA approval in November 2018 based on interim results of the ADMIRAL trail (Perl AE, et al., 2019) for monotherapy treatment of adult R/R AML with FLT3 I836 mutations. The FDA approved companion diagnostic, LeukoStrat CDx FLT3 Mutation assay, which notably uses EcoRV restriction digest to detect TKD mutations, but is unable to specify which TKD mutation (D835 or I836) is present. NCCN AML guidelines classify gilteritinib as a category 1 recommendation for R/R AML patients harboring FLT3 TKD mutations (I836 included).",
                "revision_id": 34718
            }
        },
        "errors": {}
    }
]